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Alanine-scanning mutagenesis of the histones H2A and H4 was performed in the 
model eukaryote Saccharomyces cerevisiae. Wild-type histones were replaced by the 
mutant proteins via plasmid shuffle, and the resulting mutant strains were screened for 
growth defects reflecting defects in transcriptional activation and repression of reporter 
genes. Histone mutant proteins that conferred phenotypic defects were tested for defects 
in protein-protein interactions with the help of the split-ubiquitin system. H2A E57A, 
which conferred the gal phenotype when expressed in place of wild-type H2A (indicative 
of defects in transcriptional activation of the GAL genes by Gal4p), was also defective for 
the protein-protein interaction of H2A with Gal4p. One possible explanation of this result 
is that Gal4p has to interact with H2A when it binds to its sites in the enhancers of the 
GAL genes. H4 Y51A, which caused mis-expression of a reporter fusion of the GAL1 
promoter to the URA3 open reading frame under repressive conditions (indicative of 
defects in transcriptional repression of the GAL1 promoter by Mig1p), was also defective 
for the protein-protein interaction of H4 with Mig1p. One possible explanation for this 
result is that Mig1p has to interact with H4 when it binds to its sites in the silencer of the 
GAL1 gene. H4 K91A, which also caused a glucose repression defect of the GAL1 
promoter, was defective for the protein-protein interactions with the other core histones. 
One possible explanation of this result is that glucose repression requires stable 
nucleosomes. The H2A variant H2A.Z was found to be required for both galactose 
induction and glucose repression of the GAL1 gene. The GAL1 mRNA was rapidly 
degraded when cells were exposed to glucose, which explains why the role of H2A.Z in 
glucose repression had not been observed in previous studies. 
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CHAPTER 1 INTRODUCTION 
1.1  Chromatin structure and regulation of transcription  
1.1.1 Chromatin structure 
 
If laid out end to end, the DNA in a single human individual would stretch to 5×1010 
km, 100 times of the distance between the Earth and the Sun (Latchman, 2010). Clearly, 
therefore, the DNA must be compacted in some way to fit inside a tiny cell. In the 
eukaryotic nucleus, genomic DNA is wrapped around the histone octamer to form the 
basic repeating unit of chromatin, the nucleosome. Each nucleosome is separated by a 
linker region of DNA of 55-75 bp in length that is bound by histone H1 (Bednar et al., 
1998). When isolated under conditions of low ionic strength, chromatin in its extended 
form (10 nm fiber) looks like beads (nucleosomes) on a string (DNA) in the electron 
microscope. The 10 nm fiber is then wrapped into a 30 nm spiral called a solenoid, where 
histone H1 and regulation of histone modifications are involved to maintain the 
chromosome structure. In heterochromatin and in the mitosis chromosome, the 30 nm 
fiber is further compacted by forming loops which are very closely packed, resulting in a 
10,000-fold compaction of the genomic DNA (Hyde, 2009), (Figure 1.1). 
In the nucleosome, core histones function as spools for 147 base pairs of DNA to 
wrap around in ~1.7 left-handed superhelical turns (Kornberg and Lorch, 1999). There are 
four core histones in all eukaryotes: H2A, H2B, H3 and H4. They are small, basic 
proteins (rich in lysine and arginine), with a net positive charge that facilitates their 
binding to the negatively charged DNA and neutralizes the net negative charge on the 










Figure 1.1 Architecture of a chromosome (Courtesy: Darryl Leja, National Human 
Genome Research Institute) 
The DNA in each chromosome is wrapped around spools consisting of histone proteins, 
and the spooled DNA folds up still more. Collectively, the DNA complexed to proteins is 
known as chromatin. 
 
 
Amino acid sequences of histones are remarkably well conserved among eukaryotes, 
for example, the peptide sequence of histone H4 is 92% identical between yeast and 
human (Matsubara et al., 2007), indicating the key role of the histones in nucleosome 
structure. Each of the four core histones has a similar structure, with an N-terminal tail 
and a helical region which consists of three -helices separated by two loops. The -
helical region forms a specific structure, known as the histone fold, which allows 
individual histones to associate with one another. The flexible N-terminal tails of histones, 
which extend beyond the surface of the nucleosome particle, are where most post-
translational modifications take place. Based on the crystal structure of the nucleosome, 
the histone octamer is generally depicted as a kernel of a H32-H42 tetramer associated 
with two H2A-H2B dimers (Arents et al., 1991; Luger et al., 1997), (Figure 1.2).   
The significance of nucleosome structure in terms of gene regulation is that the 
positioning of DNA within the nucleosome dictates the accessibility of a gene to the 
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general transcriptional machinery and RNAPII. The accessibility of a gene is further 
influenced by epigenetic factors, such as DNA methylation and posttranslational histone  
modifications that close or open chromatin structure leading to inactive or active 
transcription, respectively (Latham and Dent, 2007). 
 
 
Figure 1.2 Crystal structure of the nucleosome core particle 
The 147-bp DNA is wrapped around the histone octamer in ~1.7 turns of a left-handed 
superhelix. The histone octamer consists of two copies each of histones H2A (yellow), 




1.1.2 Epigenetic control of gene expression 
 
The term “epigenetic” was first introduced by Conrad Waddington in 1942 
(Waddington, 1942) to describe “the interactions of genes with their environment that 
bring the phenotype into being”. Currently, it includes all features such as chromatin and 
DNA modifications that are inheritable and stable over rounds of cell division, but do not 




1.1.2.1 DNA methylation  
DNA methylation is the most studied epigenetic process, which occurs at the carbon 
5-position of the cytosine base within the context of CpG dinucleotides, and is catalyzed 
by DNA methyltransferases (DNMTs) (Clark et al., 1995). It is now well established that 
DNA methylation generally associates with silent chromatin which is inhibitory to 
transcription initiation (Klose and Bird, 2006). One mechanism proposed for gene 
silencing by DNA methylation is mediated by proteins containing methyl-binding 
domains (MBD), which specifically recognize and bind to methylated DNA and repress 
transcription indirectly via recruitment of corepressors that modify chromatin (Clouaire 
and Stancheva, 2008). 
Although cytosine methylation is a common DNA modification in most eukaryotic 
organisms including plants, animals, and fungi (Law and Jacobsen, 2010), species such as 
yeast and many invertebrates, including the nematode C. elegans and the fly D. 
melanogaster, contain either no or barely detectable amounts of methylated cytosine in 
their genomes (Hutchins et al., 2002; Tang et al., 2012). Histone modifications are the 
main epigenetic regulatory mechanism in these organisms.  
 
1.1.2.2 Histone modifications 
The nucleosome organization of chromosomes has a generally repressive effect on 
gene expression, because access to the transcription machinery is physically impeded by 
histones. Modifications of histones typically occur as part of the process for activating 
gene transcription.  
The covalent modifications of histones include acetylation, methylation, 
ubiquitylation, sumoylation and ADP-ribosylation of lysine residues, methylation of 
arginine residues, and phosphorylation of serine, threonine and tyrosine residues. Around 
200 post-translational modifications of histones have been reported occurring at 
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approximately 60 different sites, most of which are clustered in the unstructured N-
terminal tails of histones (Kouzarides, 2007). The diversity of histone post-translational 
modifications (HPTMs) has led to the proposal of the histone code hypothesis. It 
postulates that the combination or sequence of these modifications determines the 
outcome of gene expression (Strahl and Allis, 2000). 
In general, active transcription correlates with acetylated histones H3 and H4, while 
reversal of acetylation is correlated with transcription repression. Several previously 
known coactivators are shown to contain histone acetyltransferase (HAT) activity, which 
is necessary for maximal transactivation of their target genes (Sterner and Berger, 2000), 
and studies on transcriptional corepressor also revealed that corepressors function by 
recruiting histone deacetylases (HDACs) to the promoter (Struhl, 1998). 
Unlike acetylation, histone phosphorylation can mediate seemingly contradictory 
outcomes, even at a given particular residue: phosphorylation of serine 10 on histone H3 
N-terminal domain. This histone modification is very well correlated with mitotic 
condensation of chromosomes, which is generally repressive for gene transcription, 
especially in higher eukaryotes (Nowak and Corces, 2004). On the other hand, the same 
phosphorylation mark on H3 Ser10 is also associated with activated gene transcription 
(Lo et al., 2001).  
In contrast to acetylation and phosphorylation, where the target residue can be 
modified by only a single moiety, lysines can be modified up to three methyl groups (i.e., 
mono-, di- or trimethyl). These distinct methylation levels of a given residue have been 
linked to distinct genomic activities (Lee et al., 2005). For instance, while all the 
euchromatic regions tested show dimethylation of histone H3 Lys4 in budding yeast, 
trimethylation of the same residue preferentially occurs at promoters and 5’ regions of 
active ORFs (Bernstein et al., 2002; Santos-Rosa et al., 2002). Methylation also plays a 
dual role in gene transcription: the general pattern of histone methylation in 
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heterochromatin is di- and trimethylation of lysine residues 9 and 27 of histone H3 
(H3K9me2 and K3K27me3), while monomethylation of H3K9 and H3K27 along with 
H3K4me, H3K79me and H4K20me are associated with active chromatin (Schones and 
Zhao, 2008). 
Currently, there are two mechanisms which have been commonly considered as the 
way how HPTMs affect gene regulation (Latham and Dent, 2007). First, HPTMs may 
somewhat affect the structure of chromatin, facilitating certain chromatin conformations 
or higher-order structures to permit protein factors (such as transcription factors) to reach 
their DNA targets. For instance, acetylation on lysine residues can reduce the positive 
charge of histones, thereby weakening their interaction with negatively charged DNA and 
increasing nucleosome fluidity, resulting in a more open chromatin structure (Workman 
and Kingston, 1998). Second, covalently modified histone residues may provide specific 
binding surfaces to recruit certain effector proteins which may have an activating or 
repressive effect on transcription. Over the past 10 years, multiple families of conserved 
domains that recognize modified histones have been discovered. For example, 
bromodomain-containing proteins can specifically bind acetylated lysine residues, while 
chromodomain-containing proteins can specifically bind methylated lysines (Bottomley, 
2004). However, the biological outcome of certain HPTMs does not only depend on the 
binding partners of modified histones, but also heavily depends on the chromatin and 
cellular context of such modifications (Berger, 2007).     
Similar to the studies on gene function in the 1980s that evidenced the need for a 
detailed map of the genome, the study of epigenetics requires a detailed map of epigenetic 
modifications at a genomic scale. Thanks to technological advances, scientists now are 
able to map epigenetic marks, such as DNA methylation, histone modifications and 
nucleosome positioning in large-scale epigenomics studies, making epigenetics one of the 
most rapidly expanding fields in biology.  
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1.2 Histone variants and gene control 
In addition to post-translational modifications of histones, the incorporation of variant 
histones into nucleosomes provides another regulatory mechanism of gene expression by 
directly or indirectly altering the permissiveness of chromatin (Henikoff and Ahmad, 
2005). These histone variants, as they came to be called, differ at the primary sequence 
level from their canonical relatives; and have been known as minor variants because of 
their rarity compared with major histones. They have been found in all eukaryotes and are 
generally not essential, but provide specificity to chromatin domains by possibly 
influencing the stability of nucleosomes or interacting with trans-acting factors (Ausio 
and Abbott, 2002).  
With the exception of H4, all core histones have variant counterparts, sharing 40-80% 
amino acid identity with them (Pusarla and Bhargava, 2005). In most organisms, the 
major histones are each encoded by multiple copies of genes, whereas histone variants are 
usually present as single-copy genes (Kamakaka and Biggins, 2005). Major histones are 
primarily expressed during the S phase of the cell cycle, composing the bulk of the 
cellular histones, and deposited in chromatin during DNA replication (Marzluff and 
Duronio, 2002). In contrast, histone variants are generally expressed throughout cell cycle 
and are incorporated into chromatin in a replication-independent manner at specific 
regions of genome (Henikoff et al., 2004). Besides, histone variants, like canonical 
histones, are subject to numerous covalent modifications, adding levels of complexity to 
the roles chromatin plays in various cellular processes (Hake and Allis, 2006; McKittrick 
et al., 2004). 
Although mammals have many histone variants, only two are shared among all 
eukaryotes: a histone H3 variant that plays an essential role in centromere function) and 
an H2A variant, termed H2A.Z in mammals and Htz1 in Saccharomyces cerevisiae. 
The centromere-specific H3 variant (CenH3) that replaces the major-type histone H3 
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in specialized nucleosomes at the centromere is the first histone variant to be implicated 
in specification and inheritance of a chromatin state (Palmer et al., 1991). The rapid 
evolving CenH3 protein can be found in all eukaryotes and is required for accurate 
chromosome segregation in every organism examined (Kamakaka and Biggins, 2005). It 
has been known as Cse4 (chromosome segregation) in Saccharomyces cerevisiae, CID 
(centromere identifier) in Drosophila melanogaster and CENP-A (centromere protein-A) 
in Homo sapiens. Although the homology between these CenH3 proteins is limited to 
their C-terminal histone fold domains (HFD), sharing only 34 -57% sequence identity 
(Chen et al., 2000), their essential N-terminal domains (END) are even more divergent in 
both length and amino-acid sequence, which is unalignable between CenH3 proteins from 
distant taxa (Cooper and Henikoff, 2004). Both HFD and END are essential for CenH3 
function. Although only HFD contains the centromere targeting information (Keith et al., 
1999; Sullivan et al., 1994), END is required for the binding of various kinetochore 
proteins. And the great divergence in the N-terminal tails of CenH3 proteins is most likely 
manifesting its rapid adaptive evolution with the kinetochore proteins it recruits (Cooper 
and Henikoff, 2004). 
In Saccharomyces cerevisiae, Cse4 replaces the major histone H3 in centromeric 
chromatin, and directs assembly of kinetochore, together with H4 and a nonhistone 
protein Scm3, which replaces the H2A-H2B dimer from preassembled Cse4-containing 
histone octamer (Mizuguchi et al., 2007).  
Unlike other histone variants, which possess domains distinct from those of canonical 
histones, H3.3 differs from canonical histone H3 (also known as H3.1/2) at only four 
amino acid positions. However, this rather subtle sequence difference is necessary and 
sufficient to account for unique functions of H3.3 (Ahmad and Henikoff, 2002). In 
metazoans, H3.3 is specially enriched  within actively transcribed genes and the  H3 
replacement by it has been shown to promote the initial gene activation (Schwartz and 
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Ahmad, 2005). Phylogenetic analysis also suggests that the metazoan H3.3 and the major 
H3 of Saccharomyces cerevisiae shares the common ancestor with conserved functions 
(Elsaesser et al., 2010). This is consistent with its role in histone replacement at active 
genes and promoter (Ahmad and Henikoff, 2002), as the yeast  genome is continually in a 
transcriptionally active or competent state (Lohr and Hereford, 1979).  
Among the four core histones, H2A has the largest number of variants, including 
H2A.X, H2A.Z, macroH2A and H2A-Bbd (H2A Barr body deficient) (Redon et al., 2002). 
Some H2A variants, like H2A.Z and H2A.X are conserved through evolution, playing 
important roles in transcription regulation or double-strand DNA repair, while others such 
as macroH2A and H2A-Bbd are restricted to vertebrates, marking alternative epigenetic 
states of chromosomes (Malik and Henikoff, 2003). The greatest region of variability 
among H2A variants is found to be the C-terminal tail (Ausio and Abbott, 2002), which is 
essential for the stability of nucleosomes (Eickbush et al., 1988). 
H2A.X is a histone H2A variant in higher eukaryotes, but the “normal” histone H2A 
in Saccharomyces cerevisiae (Downs et al., 2000). The core sequence of H2A.X is nearly 
identical to that of the major vertebrate H2A, while its C-terminal tail is longer and 
contains a SQ(E/D)(I,L,F,Y) motif, which is also found in the C-terminal tails of some 
major H2As from lower eukaryotes, suggesting its conserved functions (Thatcher and 
Gorovsky, 1994). The serine in the SQ motif (Ser129 in budding yeast and Ser139 in 
mammals) is the site of rapid phosphorylation by phosphatidyl inositol 3’-kinase-related 
kinases (PIKK, such as ATM in human cells and Mec1 in yeast), in response to DNA 
double-strand breaks (Morrison and Shen, 2005). The addition of a bulky phosphate 
group with negative charges may change the chromatin structure surrounding the DNA 
lesion so as to allow greater accessibility of the DNA to modulating enzymes and repair 
factors and facilitate the assembly of repair complexes at lesion sites (Downs et al., 2000). 
Unlike H2A.X, which could be found throughout the genome, the vertebrate-specific 
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H2A variants, macroH2A is enriched in the inactive X-chromosome (Chadwick and 
Willard, 2002). It has been shown that the globular C-terminal domain of macroH2A can 
inhibit transcription factors binding and its histone-fold domain can interfere with 
chromatin remodeling by SWI/SNF complexes, thus suggesting its general role in 
establishment of silent chromatin structure (Angelov et al., 2003). Besides, its C-terminal 
“macro” domain contains a leucine-zipper motif that has been implicated in protein 
dimerization. Such dimerization in macroH2A-containing nucleosomes might facilitate 
inter-nucleosome interactions, thereby promoting the compaction of large chromatin 
domains (Sarma and Reinberg, 2005). In mammalian female cells, macroH2A appears to 
replace canonical H2A during X chromosome inactivation and may be involved in the 
generation or maintenance of the Barr body.  
In contrast, the other vertebrate-specific H2A variant, H2A-Bbd, named for its 
relative depletion from Barr bodies in mammals, is largely excluded from the inactive X-
chromosome, but enriched in nucleosomes associated with transcriptionally active region, 
colocalizing with the acetylated histone H4 (Chadwick and Willard, 2001). The lack of a 
significant C-terminal tail of H2A-Bbd has been postulated to destabilize the nucleosome, 
thus aiding in ease of nucleosome displacement during transcription, and consistent with 
its localization to the active X chromosome and autosomes (Gautier et al., 2004).  
The histone H2A variant H2A.Z (also known as H2A.Z/F, H2AvD, hv1 or Htz1) is 
highly conserved throughout evolution with 90% sequence homology between species 
(Iouzalen et al., 1996), even more similar across species than is canonical H2A, and 
makes up approximately 5~10% of all cellular H2A proteins in most organisms tested to 
date (Leach et al., 2000; Redon et al., 2002). However, the sequence similarity between 
H2A.Z and canonical H2A is only 60%, which suggests unique and important functions 
for H2A.Z (Jackson and Gorovsky, 2000; Thatcher and Gorovsky, 1994). It has been 
shown that H2A.Z is important in several processes, such as gene activation, 
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heterochromatin-euchromatin boundary formation and cell-cycle progression (Dhillon et 
al., 2006; Meneghini et al., 2003; Zhang et al., 2005).  
The crystallographic structure data of H2A.Z-containing nucleosome showed a subtle 
destabilization of the interaction between the H2A.Z/H2B dimer and the H3/H4 tetramer 
(Suto et al., 2000).  And the biochemical analysis of chromatin fibers also showed 
reduced salt stability of nucleosomes containing H2A.Z (Zhang et al., 2005). Taken 
together, it seems that unstable H2A.Z-containing nucleosomes may result in loss of 
nucleosomes from specific region of DNA, allowing transcriptional regulatory proteins to 
bind (Zhang et al., 2005). 
Studies of genome-wide localization of H2A.Z has revealed that it is incorporated 
into nucleosomes near, but not at centromeres, at the borders of heterochromatic domains, 
and near the promoters of 63% genes (Guillemette et al., 2005; Li et al., 2005; Raisner et 
al., 2005; Zhang et al., 2005). Given its widespread locations in most promoters, one 
might anticipate that H2A.Z plays important roles in transcription.  
The gene encoding H2A.Z has been shown to be essential in most organisms, from 
ciliated protozoans to mammals (Liu et al., 1996), whereas yeasts with deletion of the 
H2A.Z gene are viable and exhibit a variety of phenotypes, which could help us 
understand multiple regulatory roles of H2A.Z playing in diverse biological processes 
(Carr et al., 1994; Jackson and Gorovsky, 2000). Given my research interest in the gene 
regulation by histones, the following section will be devoted to the important roles that 








1.2.1 H2A.Z (Htz1) and the transcriptional regulation in Saccharomyces cerevisiae 
The earliest evidence of H2A.Z correlating with transcriptional activity comes from 
Tetrahymena thermophila, where H2A.Z (termed as hv1) is preferentially associates with 
the transcriptionally active macronucleus rather than with the silent micronucleus, 
implying a positive role for H2A.Z in gene transcription (Allis et al., 1980). However, 
about 30 year later, the molecular function of H2A.Z in transcription remains obscure.  
In Saccharomyces cerevisiae, Htz1, the ortholog of mammalian H2A.Z, is the sole 
histone H2A variant and is encoded by HTZ1 (Jackson et al., 1996). The loss of has 
relatively minor effect on gene expression profile Htz1 in Saccharomyces cerevisiae, 
typically affecting only the transcriptional kinetics of a subset of inducible genes 
(Meneghini et al., 2003).  
It has been proposed that Htz1 positively regulates gene transcription by modulating 
interactions with RNA polymerase II associated factors (Adam et al., 2001; Marques et al., 
2010; Wan et al., 2009) and by remodeling chromatin structure (Santisteban et al., 2000). 
Genome-wide location studies have revealed that Htz1 preferentially associates with the 
two nucleosomes flanking the nucleosome free region (NFR) of promoters (Albert et al., 
2007). The distinctive enrichment of Htz1 at promoter proximal nucleosomes has led to 
the pervasive view that H2A.Z is the key regulator of transcription that creates a more 
permissive environment for transcription activation, but we still lack a clear 
understanding of precisely how this substitution affects nucleosome stability and 
interactions (Rando and Winston, 2012). 
H2A.Z occupancy has been found to negatively correlate with transcription levels, 
with H2A.Z being highly enriched in most gene promoters but depleted upstream of very 
highly transcribed genes, which has been interpreted to suggest that Htz1 helps to poise 
promoters for activation (Zanton and Pugh, 2006; Zhang et al., 2005).  
The biological importance of fine nucleosome positioning is made clear by the 
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topological relationship of transcription factor binding sites and transcriptional start sites 
with the DNA wrapped in a nucleosome (Albert et al., 2007). In yeast, it has been 
demonstrated that transcription factor binding sites tend to be rotationally exposed on the 
H2A.Z nucleosome surface near its border, while transcriptional start sites tend to reside 
about one helical turn inside the nucleosome border (Albert et al., 2007). Others have 
observed that H2A.Z incorporation within a nucleosome leads to repositioning of a subset 
of nucleosomes to a new position. Indeed, this stabilization leads to less variability in 
H2A.Z nucleosome positions in a population of cells, when compared to H2A 
nucleosome positions. One can imagine that depending on where nucleosomes are 
repositioned, positive or negative effects on gene expression could be observed (Marques 
et al., 2010). 
 
1.3 Yeast as a model eukaryote 
1.3.1 Features of the yeast as a eukaryotic model organism 
Because of the remarkable conservation of basic biological structures and processes 
throughout evolution, the results from basic research on model organisms such as the 
bacteria Escherichia coli, the yeast Saccharomyces cerevisiae, and the fruit fly 
Drosophila melanogaster, typically would apply more generally. The yeast 
Saccharomyces cerevisiae is perhaps the best-studied eukaryotic organism and also the 
first eukaryote of which the complete genome was sequenced (Goffeau et al., 1996). 
Since its introduction as a model organism for molecular biology around 1960, it has 
yielded a variety of industrial and medical applications beneficial to human life.  
The yeast is microscopic and easy to manipulate like bacteria, but it is a eukaryote, 
evolutionarily closer to animal than plant. In fact, many human genes related to disease 
have orthologues in yeast (Ploger et al., 2000), and the high conservation of metabolic 
and regulatory mechanisms has contributed to the wide-spread use of yeast as a model 
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eukaryotic system for diverse biological studies. It is non-pathogenic, so can be handled 
with few precautions. It has a relative short life cycle, so that a large number of 
generations occur within a short time, making it possible to obtain data readily over many 
generations. Normal laboratory haploid yeast strains have a doubling time of 
approximately 90 min in yeast-extract peptone dextrose medium and approximately 140 
min in synthetic medium during the exponential phase of growth (Sherman, 2002).  
The genome of yeast is relatively small, constituting 12,052 kb, which is only about 
3.5 times larger than that of E. coli and about 200 times smaller than the human genome, 
and only 3.8% of its ORFs contain introns (Spingola et al., 1999). Laboratory yeast 
strains can be maintained in stable haploid state with a set of well-characterized 16 
chromosomes due to a mutation in the gene encoding HO endonuclease required for 
homothallic switching, which is essential for the utility of yeast as a genetic model system. 
The highly versatile and efficient DNA transformation system established in yeast 
makes it particularly accessible to gene cloning and genetic engineering techniques. 
Plasmid can be introduced into yeast cells either as replicating molecules or by 
integration into the genome. And the integrative recombination of transforming DNA in 
yeast proceeds exclusively via homologous recombination. Cloned yeast sequences can 
therefore be directed at will to specific locations in the genome.  
The yeast combines several advantages of many model organisms, making it a 
powerful model genetic system to functionally dissect many highly conserved eukaryotic 
cellular processes. 
 
1.3.2 Genetic nomenclature for Saccharomyces cerevisiae 
The universally accepted genetic nomenclature for the yeast is as the following: each 
gene is designated by three italicized uppercase letters followed by a number (e.g., GEN1), 
while proteins encoded by GEN1, for example, can be denoted Gen1p. Names of all the 
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genes and their encoded proteins in this study are listed in Table 1.1.  







HTZ1 Htz1 (H2A.Z in yeast)
URA3 Ura3p 
 
Table 1.1 Names of the genes and their encoded proteins in this study       
For the four core histones in yeast, there are two copies of genes encoding for each of 
them. Cells are not viable with both copies of the histone genes deleted.  
  
Symbols are commonly used to designate certain types of experimentally manipulated 
gene structures. The symbol “”can denote a complete ORF deletion. Gene disruptions 
are typically represented with a double colon “::” and gene fusion constructs are often 
designated with a dash (Demerec et al., 1966). 
Phenotypes are denoted by cognate symbols in Roman type and by the superscripts + 
and . For example, the independence and requirement for uracil can be denoted Ura+ and 
Ura.  
The two wild-type alleles of the mating-type locus are designated MATa and MAT. 
The mating phenotype of MATa and MAT are denoted simply as a and , respectively 
(Guthrie and Fink, 2004). 
 
1.3.3 Yeast vectors and transformation 
 
In general, transformation is referred to the introduction of exogenous DNA into cells 
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and the subsequent inheritance and expression of that DNA. A wide range of vectors are 
available to meet various requirements for insertion, deletion and expression of genes in 
yeast. Most plasmids used for yeast studies are shuttle vectors, which contain sequences 
permitting them to be selected and propagated in E. coli, thus allowing for convenient 
amplification and subsequent alteration in vitro (Kumar and Garg, 2006). In addition, all 
yeast vectors contain markers that allow selection of transformants containing the desired 
plasmid. The most commonly used yeast markers include URA3, HIS3, LEU2, TRP1 and 
LYS2, which complement specific auxotrophic mutations in different yeast strains (Tuan, 
1997). 
The yeast shuttle vectors used currently can be broadly classified into the following 
three types: integrative vectors, YIp; autonomously replicating high copy-number vector, 
YEp; or autonomously replicating low copy-number vectors, YCp (Parent et al., 1985; 
Struhl et al., 1979).  
The YIp integrative vectors do not replicate autonomously, but integrate into the 
genome by homologous recombination. The site of integration can be targeted by cutting 
the yeast segment in the YIp plasmid with a restriction endonuclease and transforming the 
yeast strain with the linearized plasmid. The linear ends are recombinogenic and direct 
integration into the site in the genome that is homologous to these ends. Strains 
transformed with YIp plasmids are extremely stable, even in the absence of selective 
pressure (Struhl et al., 1979). 
The YEp yeast episomal plasmid vectors replicate autonomously because of a 
segment of the yeast 2 m plasmid that serves as an origin of replication (2 m ori). Most 
YEp plasmids are relatively unstable. Even under conditions of selective growth, only 
60% to 95% of the cells retain the YEp plasmid (Struhl et al., 1979). 
The YCp yeast centromere plasmid vectors are autonomously replicating vectors 
containing centromere sequences, CEN, and autonomously replicating sequences, ARS. 
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The YCp vectors are typically present at very low copy numbers, from 1 to 3 per cell. 
During mitosis, they mimic the behavior of chromosomes. The ARS sequences are 
believed to correspond to the natural replication origins of yeast chromosomes. The CEN 
sequence is required for mitotic stabilization of YCp vectors. The stability and low copy 
number of YCp vectors make them the ideal choice for cloning vectors for investigating 
the function of genes altered in vivo (Parent et al., 1985). 
 
1.3.4 URA3 gene  
Yeast cells that contain plasmids are typically selected using nutritional markers; for 
example, by putting a LEU2 gene required for leucine biosynthesis on a plasmid and 
transforming it into a leu2 mutant yeast strain. However, some markers can be used for 
negative (counter-) selection, to select cells that have lost the plasmid.    
The URA3 yeast gene is probably the most used marker of all, because it has both 
positive and negative selection properties. Positive selection is carried out by auxotrophic 
complementation of the ura3 mutation, whereas negative selection is based on the 
specific inhibitor, 5-fluoro-orotic acid (FOA) that prevents growth of the Ura cells but 
allows growth of the Ura- cells (Boeke et al., 1984).  
URA3 gene encodes the orotidin 5-phosphate decarboxylase, an enzyme which is 
required for the biosynthesis of uracil. Ura cells can be selected on media containing 
FOA. The Ura+ cells are killed because FOA is converted to the toxic compound 5-
fluorouracil by Ura3, whereas Ura cells are resistant. The negative selection on FOA 
media is highly discriminating, and usually less than 10-2 FOA-resistant colonies are Ura+. 
The FOA selection procedure can be used for expelling URA3-containing plasmids. 
Because of the negative selection property and the small size of URA3 gene, it becomes 




1.3.5 Plasmid shuffle 
 
Construction of a null allele in yeast is quite straightforward using one-step 
replacement methods if the gene product is not essential for yeast survival, however, the 
testing of phenotypes of a mutant gene becomes a problem if the gene product has an 
essential function. Plasmid shuffle is the most common procedure for isolating and 
characterizing a series of altered alleles in such case (Michels, 2002). First, a strain 
containing the chromosomal null allele and a plasmid-borne wild-type allele is 
constructed. A second plasmid carrying the mutant allele of the gene and a different 
nutritional marker for selection is transformed into the same host cell. The doubly 
transformed host cell is grown under conditions that select for the maintenance of the 
second plasmid but not the first plasmid. If the first plasmid can be lost, and the mutant 
gene on the second plasmid is functional, then the phenotype of the mutant can be studied. 
If the strain can never survive without the first plasmid with wild-type allele, then the 
mutant gene on the second plasmid is nonfunctional, i.e., unable to complement the wild-
type allele. URA3 is often used in this strategy because its counter-selection property 
makes it easy to be kicked out cells grown on FOA-containing media (Sikorski and Boeke, 
1991). In this case, only cells that have lost the wild-type gene on the URA3 plasmid can 
grow on the 5-FOA plates, and the phenotype conferred by the mutant plasmid can be 
investigated. 
Unlike higher eukaryotes where there are multiple copies of each histone gene, 
distributing over several chromosomes, Saccharomyces cerevisiae only contains two 
copies of each histone, which has made the manipulation of yeast histone genes much 
easier. In the yeast background where both copies of a histone gene have been deleted, a 
copy of this histone gene can be carried by a URA3 plasmid to sustain the survival of 
yeast. A second copy of the histone can be introduced on a second plasmid, carrying a 
different selectable marker. This second copy was mutated by site-directed mutagenesis, 
19 
 
and then the first, wild-type copy can be selectively lost from the cells using 5-FOA, 
which causes the URA3 gene product to be toxic to the cell. The end result is that the only 
copy present in the cell is the altered second copy, which contains any number of 
mutations to be tested.  
 
1.3.6 The yeast GAL genes and their expression control 
 
In Saccharomyces cerevisiae, several enzymes are required to catalyze the conversion 
of galactose to a more metabolically useful version, glucose-6-phosphate. GAL1, GAL7 
and GAL10 are the genes encoding structural enzymes of the Leloir pathway and form a 
cluster of similarly regulated genes located on chromosome II (Schmid et al., 2006).  
In glucose, carbon catabolite repression ensures that GAL genes expression does not 
occur even if galactose is available to the cell. The repression of the GAL genes by 
glucose is largely controlled by the repressor protein Mig1p (Nehlin et al., 1991), which 
interacts with the general corepressor complex Tup1p-Cyc8p, inhibiting the transcription 
of GAL genes (Edmondson et al., 1996; Wahi et al., 1998). 
When the yeast is grown on glycerol or raffinose, the GAL genes are not expressed, 
but their activation is not repressed. This is to allow rapid induction of GAL genes 
expression, which will occur within 30 min of adding galactose to the culture (St John 
and Davis, 1981). When galactose is the preferred carbon source, the GAL structural 
genes are actively transcribed and the transcription can be induced by more than 1000-
fold (Johnston, 1987; Johnston et al., 1994). 
The transcription of the GAL genes is tightly controlled by the GAL genetic switch 
composed of a transcriptional activator (Gal4p), a transcriptional inhibitor (Gal80p), and 
a transcriptional inducer/ligand sensor (Gal3p) (Sellick et al., 2008). Unlike the other 
GAL genes, the expression of GAL3 and GAL80 occurs at a low level even under 
repressing conditions, as the basal expression of GAL3 and GAL80 is required for the 
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GAL genes induction (Lohr et al., 1995).  
The regulation of the transcriptional activity of the GAL genetic switch is largely 
dependent on protein-protein interactions between Gal4p and Gal80p and between 
Gal80p and Gal3p. In the presence of galactose, Gal3p binds with galactose and ATP, and 
in this state, Gal3p can bind with Gal80p and hold it in the cytoplasm, thus freeing Gal4p 
from the inhibitory effects of Gal80p in the nucleus and enabling transcriptional 
activation to occur. (Peng and Hopper, 2000; Peng and Hopper, 2002), (Figure 1.3). In the 
absence of galactose, Gal3p cannot bind Gal80p. Gal80p is, therefore, free to enter the 
nucleus, where Gal80p binds to Gal4p, preventing the recruitment of transcription 
machinery to GAL genes (Li et al., 2010).  
 
Figure 1.3 GAL genes transcription upon galactose induction  
Upon galactose induction, the interaction between Gal3p and Gal80p in cytoplasm results 
in a reduction of Gal80p concentration in nucleus, thereby, enabling Gal4p to interact 
with the transcriptional machinery (Sellick et al., 2008).   
 
1.4 Alanine-scanning mutagenesis  
In this study, the alanine scanning for histones was performed by systematically 
substituting each non-alanine amino acid within histone proteins to alanine, with the 
exception of endogenous glycine residues, using site-directed mutagenesis. As not all 
functions of histone proteins can be attributed to modification state, alanine scanning is 
useful to identify the precise residues involved in histone function and considered to be 
higher resolution screen compared to the deletion scanning mutagenesis. The 
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consequence of each mutation on histone functions was assessed by phenotypic tests later.  
Alanine is used for replacement of other amino acids is because: it does not have any 
side chain beyond the carbon; it does not alter the main chain conformation as glycine 
and proline; it does not impose strong steric and electrostatic effects; and alanine is the 
most abundant amino acid in nature and can be found in buried or exposed positions, and 
in all secondary structures. The power of alanine-scanning mutagenesis to provide critical 
biological insight has been demonstrated by a few important early examples such as the 
enzymatic activity of kinases (Gibbs and Zoller, 1991) and lysozyme stability (Blaber et 
al., 1995).  
 
1.5 Phenotypic analysis  
In this study, phenotypic analysis of histone single mutations on the transcription 
initiation of specific genes is carried out by spotting fixed amounts of mutant cells on 
solid media containing different chemical agents. As the spot assay is a simple yet 
informative method to measure yeast growth quantitatively, the effects of histone single 
mutations altering transcription regulation are manifested by the reduction in growth of 
these mutants in response to specific drugs. Under different phenotypic testing conditions, 
some yeast mutants not only grow more slowly but also form fewer colonies. Therefore, 
the spot assay measures both the efficiency of plating by colony formation frequency and 
the growth rate by colony size. In our phenotypic analysis, the regulation of transcription 
initiation of GAL genes, URA3 gene and HIS3 gene has been investigated. The follows 
are the underlying mechanisms of each phenotypic test. 
 
1.5.1 Antimycin A (AA) sensitivity – Indicator for defects in the transcription 
activation of the GAL genes by Gal4p 
Antimycin A is a chemical compound produced by streptomyces bacteria (Dunshee et 
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al., 1949). It prevents the consumption of oxygen by inhibiting the oxidation of ubiquinol 
in the electron transport chain and ultimately prevents the formation of ATP (Miller and 
Gennis, 1983). The oxygen deprivation of yeast growing under catabolite non-repressed 
conditions (galactose) results in the abrupt decrease in energy production and slowing of 
growth (Lai et al., 2006).  
In the absence of AA, yeast can still grow in galactose medium even without 
transcription activators of GAL genes because the basal expression level of GAL genes is 
sufficient for their energy generation (by converting galactose to CO2) under the aerobic 
condition. However, in the presence of AA, the respiration of cells is inhibited, meaning 
that most galactose can only be converted to intermediates, not CO2. In this case, the 
efficiency of energy generation becomes very low, and to sustain the cell growth, cells 
need higher transcription level of GAL genes to compensate for the low energy 
conversion efficiency. If the transcription of the GAL genes is impaired, in the presence of 
AA, cells would display growth defects in galactose. Therefore, sensitivity to AA can 
indicate defects in the transcription activation of GAL genes by Gal4p. 
 
1.5.2 6-Azauracil (6-AU) sensitivity – Indicator for defects in transcription activation 
by Ppr1p of the URA3 gene or defects in transcription elongation 
6-Azauracil (6-AU) is a uracil analog, which upon entry into the yeast cell is 
converted to 6-azaUMP (uridine monophosphate) and in this form acts as a competitive 
inhibitor of orotidine 5-phosphate decarboxylase (OMPdecase), which is encoded by the 
URA3 gene (Liljelund et al., 1984). In the presence of 6-AU, the OMPdecase level in the 
wild-type strain is increased three to fivefold; whereas mutants unable to induce this 
enzyme will consequently be sensitive to 6-AU (Liljelund et al., 1984).  
The alleles of PPR1 and PPR2 have been found exhibiting sensitivity to 6-AU 
(Exinger and Lacroute, 1992; Loison et al., 1980). The gene PPR1 (pyrimidine pathway 
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regulator 1) encodes a positive transcriptional regulator of pyrimidine pathway genes 
URA1, URA3 (Loison et al., 1980) and the sensitivity of ppr1 mutant strains to 6-AU can 
be suppressed by addition of uracil to the medium (Exinger and Lacroute, 1992). PPR2, 
the gene encoding a general transcription elongation regulator TFIIS (Nakanishi et al., 
1992), is a regulatory gene for URA4 (Hubert et al., 1983). The sensitivity of ppr2 mutant 
strains to 6-AU is thought to be a consequence of the TFIIS requirement of elongating 
RNA polymerase II under conditions of NTP (nucleoside triphosphate) deprivation, and 
can be rescued by addition of uracil or guanine to the medium (Archambault et al., 1992). 
Therefore, sensitivity to 6-AU often correlates with defects in the transcription 
activation of the URA3 gene by Ppr1p or defects in the elongation phase of transcription 
by RNA polymerase II.  
 
1.5.3 3-Amino-1, 2, 4-triazole (3-AT) sensitivity – Indicator for defects in 
transcription activation of the HIS3 gene by Gcn4p 
The HIS3 gene, which encodes a histidine biosynthetic enzyme (Fink, 1964), is 
regulated in response to histidine starvation and its induction is activated by Gcn4p (Hope 
and Struhl, 1985). The histidine analog, 3-amino-1,2,4- triazole (3-AT) is a competitive 
inhibitor of the HIS3 gene product, imidazoleglycerol phosphate dehydratase (Alexandre 
et al., 1993; Kishore and Shah, 1988). In the absence of 3-AT, the basal expression level 
of the HIS3 gene is sufficient for the synthesis of histidine even without the activator 
Gcn4p. While exposure of yeast cells to 3-AT causes histidine starvation, and cells need 
to increase the transcription level of the HIS3 gene in order to compensate the 
competition between 3-AT and imidazoleglycerol-phosphate for the enzyme. If the 
activation of HIS3 transcription is impaired, cells would display sensitivity to 3-AT. Thus, 
3-AT is commonly used to measure the level of the HIS3 gene expression required for 
growth on medium lacking histidine and screen for mutants that are defective in the 
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activation of HIS3 gene transcription (Hampsey, 1997).  
 
1.6 Multicopy suppressor screening 
Multicopy suppressor screening is a standard procedure to find a genetic link to a 
gene of your interest. Practically, the yeast strain that has a defect (for example, growth 
defect due to the mutation of a certain gene) is transformed with a multicopy library. The 
library is a set of plasmid DNA which carries a wide variety of DNA fragments from the 
genome in the multicopy vector, leading to the overexpression of different gene products. 
If a gene product “cures” the defect caused by a mutation of the other gene, there must be 
a functional link between these two genes. Then the plasmid DNA will be isolated from 
yeast transformants and the gene locus on it can be identified by DNA sequencing and 
homology search using BLAST. Finally, the genetic link found can be evaluated by 
bioinformatic analysis of identified genes (Rine et al., 1983).  
In this study, a multicopy suppressor screen for the genes that suppress the 
temperature sensitivity and 3-AT sensitivity of histone mutant strains was conducted. In 
general, a mutant strain having a clear and pronounced phenotype is used to isolate the 
genes suppressing the original mutant phenotype from a multicopy genomic DNA library. 
And the library plasmid bearing the multicopy suppressor needs to be retransformed back 
to the original mutant to demonstrate a direct link between the suppressor effect and the 
gene present on the plasmid. The suppression can be obtained by compensating partially 
for the loss of function of the mutant histones. 
Although the multicopy suppressor approach is easy to perform and leads to the 
concomitant cloning of the suppressor gene, in some cases the suppression does not 
reveal a direct interaction, but rather may reflect two different independent functions that 
indirectly influence each other. Therefore, a follow-up analysis of the isolated suppressors 
is necessary to elucidate its suppression mechanism. 
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1.7 Split-ubiquitin system 
Protein-protein interactions are involved in all cellular processes and crucial for all 
levels of cellular function. The presence of protein interaction networks is a key property 
of complex biology systems. A large number of methods have been developed for 
screening protein interactions. Yeast two-hybrid technique is a well established genetic in 
vivo approach to detect interacting proteins in living yeast cells. It is based on expressing 
one protein as a fusion to a DNA-binding domain of a transcriptional activator and 
expressing another protein as a fusion to a transcriptional activation domain. If the test 
proteins interact in vivo, a transcriptional activator is reconstructed, resulting in the 
induction of a reporter gene (Chien et al., 1991; Fields and Song, 1989). Thus, the classic 
yeast two-hybrid system is not suitable for interaction analysis with proteins that can 
directly activate transcription, for such transactive baits would trigger transcription in 
absence of any interaction with a prey.  In addition, this otherwise powerful method limits 
the set of detectable protein interactions to those that occur in the nucleus, in proximity to 
the reporter gene (Chien et al., 1991). Whereas the split-ubiquitin system designed by 
Johnsson and Varshavsky in 1994 (Johnsson and Varshavsky, 1994) allows detection of 
protein-protein interactions occurring anywhere inside the cell and is suitable to screen 
transactive baits. 
Ubiquitin is a small protein important for the turnover of cellular proteins. Proteins 
are labeled for proteasomal degradation by covalently attaching a poly-ubiquitin chain. 
This chain is then cleaved off prior to protein degradation by ubiquitin specific proteases 
(USP) (Ozkaynak et al., 1987). 
The split-ubiquitin technique is based on separation of ubiquitin into two independent 
fragments. It has been shown that ubiquitin can be split into an N-terminal (Nub) and a C-
terminal (Cub). Efficient reassociation into a native-like ubiquitin is only observed if the 
two moieties are brought into close proximity by the interaction of two proteins fused to 
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Nub and Cub respectively. Reconstituted split-ubiquitin is recognized by USPs, which then 
cleave off any reporter protein fused to the C-terminal end of Cub (Johnsson and 
Varshavsky, 1994). 
In this assay, N-terminally modified Ura3p (RUra3p) has been used as a reporter 
protein because of the counter-selection property of Ura3p as mentioned in the previous 
section. RUra3p is Ura3p with the first amino acid replaced by arginine. Interaction 
between bait and prey leads to ubiquitin reconstitution and subsequent cleavage of 
RUra3p by Ubps from Cub, exposing the arginine for rapid degradation according to the 
N-end rule (Varshavsky, 1997). With the rapid destruction of RUra3p, the yeast cells can 
no longer grow on media lacking uracil, but become resistant to media containing 5-FOA. 
This system is not based on a transcriptional readout and can therefore be applied to 
nuclear, cytoplasmic and membrane proteins (Kerkmann and Lehming, 2001; Laser et al., 
2000) (Figure 1.4). 
 
Figure 1.4 Split-ubiquitin system 
Interaction between protein X and Y, which has been fused to Cub and Nub respectively, 
reconstitutes ubiquitin and leads to cleavage and degradation of the reporter protein 
(Ura3p) (Bruckner et al., 2009). 
 
 
The split-ubiquitin system detects a spatial proximity of proteins but not necessarily 
their direct interactions. Therefore, the signal might also result from the binding of test 
protein to a common ligand – another protein or a larger structure. It is necessary to use 
more than one method to validate a protein-protein interaction identified via split-
ubiquitin system. Biochemical methods such as pull down assay, allow the study of 
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physical interactions of proteins, but pull down assays require a certain stability of the 
protein complex. Moreover, many of these methods are relatively labor intensive and can 
only be applied to a small number of interactions detected in larger screens. Meanwhile as 
the design of the split-ubiquitin system poses steric constraints on the two fusion proteins, 
almost all protein-protein interactions detected by the split-ubiquitin system are direct 
ones, although these constraints might lead to some false-negative results as well 
(Lehming, 2002).  
Proper controls are needed to prove the relevance of results generated by split-
ubiquitin system. Proteins which allow yeast to overcome nutritional selection, when 
overexpressed can cause false positive results. The high expression level of bait and prey 
and their co-localization in a compartment may not correspond to their natural cellular 
environment. 
 
1.8 Chromatin immunoprecipitation assay  
Chromatin immunoprecipitation (ChIP) was developed to detect the in vivo binding 
sites of chromosomal proteins (Solomon et al., 1988). It is a key technique for chromatin-
related studies and has become widely used assay in the field of molecular biology for 
investigating gene regulation (Orlando, 2000). 
The first step of ChIP is typically exposing the cells to a nonspecific crosslinking 
agent, usually formaldehyde, which penetrates cells rapidly and joins large molecules to 
their nearest neighbors by creating covalent bonds between their amino groups (McGhee 
and von Hippel, 1975) (Figure 1.5). Due to the high crosslinking efficiency of 
formaldehyde, cells are killed instantly and all ongoing processes at the time of fixation 
are arrested, providing the snapshot of cellular activity. Because of the ability of 
formaldehyde to produce both protein-protein and protein-DNA crosslinks, the protein to 
be analyzed do not necessarily have to bind to DNA directly, but can be crosslinked to 
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DNA via other proteins such as the histones. This step also ensures the efficient recovery 
of protein-DNA complexes during the subsequent manipulations. 
Following crosslinking, the chromatin (DNA complexed with proteins cross-linked to 
it) is isolated and fragmented by exposure to high frequency sound waves emitted by a 
sonicator (Figure 1.5). This generates a range of DNA fragments with sizes of 200 to 
1000 bp. This step is an important determinant of the resolution and sensitivity of the 
ChIP assay, because proteins tend to interact with relatively small sites on DNA (5- 30 bp), 
while the unsonicated DNA can be 20 kb or larger, spanning several genes (Xiao, 2006). 
To allow precise mapping of the genomic location of any protein, it is thus necessary to 
cleave the chromatin into small fragments. 
These small chromatin fragments are then incubated with the antibody against the 
protein of interest itself, or against the epitope which was used to tag it. The success of 
any ChIP assay depends on the specificity and reactivity of antibodies used to capture the 
protein of interest. The ease of gene-tagging in yeast system has greatly accelerated the 
use of ChIP analyses, because, theoretically, any protein can be studied without the time 
or expense required to raise antibodies against native proteins. The major downside of 
using epitope tags is that tagging a protein, even one expressed from it endogenous locus, 
can alter its function. Thus, when employing tagging methods, it is important to make 
sure that the presence of the epitope does not substantially interfere with the functional 
characteristics of the protein.  
After washing away unbound material, the remaining material contains the protein of 
interest still crosslinked to any DNA it was attached with in vivo. As the covalent bonds 
formed by formaldehyde can be broken with gentle heat, the crosslinks can be easily 
reversed by heat treatment. The freed-up DNA can be then purified and analyzed by real-
time PCR. The purified DNA can also be labeled in bulk and hybridized to a DNA 
microarray, which is known as “ChIP on chip” (Collas and Dahl, 2008). This variation of 
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ChIP assay allows researcher to investigate the localization pattern of a given protein 
across large genomic regions or even entire genome.  
In addition to revealing the presence of a specific protein at a given DNA sequence 
under different conditions such as heat shock, galactose induction, etc., highly specialized 
antibodies can provide even more detailed information. For example, antibodies can be 
developed that distinguish between different posttranslational modifications of the same 
protein. As a result, ChIP can identify the different modification status of the protein of 





Figure 1.5 Summary of chromatin immunoprecipitation methodology 
Living cells are fixed with formaldehyde and chromosomal proteins are crosslinked to 
DNA in vivo. The chromatin is then sheared by sonication into small fragments. The 
antibody specific to the protein of interest is added and the complex is isolated by 
immunoprecipitation. Following the reversal of crosslinking, the enriched DNA is 
purified. PCR and other assays are used to determine the DNA regions bound by the 




1.9 Implications of histone modifications in human diseases  
Changes in chromatin structure are an essential prerequisite for activation and 
repression of transcription. Post-translational histone modifications can change chromatin 
structure, and therefore affect gene expression, playing a key role in maintaining normal 
development of cells. Deregulation in any of these histone modifications may shift the 
balance of gene expression leading to cellular transformation and malignant outgrowth. 
Altered histone modification patterns have been observed at a variety of different gene 
loci in human tumors compared to the corresponding normal human cells.  
The most prominent alteration in histone modifications in cancer cells is a global 
reduction of monoacetylated H4K16 (Fraga et al., 2005). Loss of acetylation is mediated 
by HDACs, which have been found to be overexpressed (Zhu et al., 2004) or mutated 
(Ropero et al., 2006) in different tumor types. In addition to aberrant activity of HDACs, 
several types of cancer cells also bear translocations leading to the formation of aberrant 
fusion proteins, mutations or deletions in HATs and HAT-related genes (Bryan et al., 2002; 
Moore et al., 2004), thus contributing to the global imbalance of histone acetylation.  
Besides the global loss of histone H4 K16 acetylation, cancer cells suffer a global loss 
of the active mark H3 K4me3 and the repressive mark H4 K20me3, and a gain in the 
repressive marks H3 K9me and H3 K27me3. Altered distribution of the histone methyl 
marks in cancer cells is mainly due to the aberrant expression of both histone 
methyltransferases and histone demethylases (Chi et al., 2010). For example, in patients 
with leukemia, the chromosomal translocations occur in a gene called MLL1 (mixed 
lineage leukemia) encoding a histone methyltransferase which is able to methylate 
histone H3 on lysine 4, resulting in the MLL targeted genes having an open chromatin 
structure. The consequent formation of aberrant fusion proteins, whose methyltransferase 
activity is lost or reduced, causes MLL targeted genes being repressed. Some histone 
demethylases have also been shown to be upregulated or amplified in several cancers, 
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including prostate cancer and squamous cell carcinomas. With the advent of high-
throughput and genome-wide profiling of epigenetic changes, more discoveries of histone 
modification pattern alterations in human cancers are likely be reported in coming years.    
The striking reconfiguration of histone marks in cancer cells compared to its normal 
counterparts represents an attractive target for biomarker discovery. The diagnostic 
advantage of them as epigenetic biomarkers partly lies in the fact that they can be 
assessed in body fluids of cancer-bearing individuals. Since it has been shown that plasma 
contains, in addition to genomic DNA, free nucleosomes (Chan et al., 2003; Rumore and 
Steinman, 1990), several studies attempt to detect histone modifications including 
methylated histone H3 K9 in plasma using cell free nucleosomes combined with ELISA 
and real-time PCR (Deligezer et al., 2008). Although these studies are in early stages, the 
presence of cancer-derived nucleosomes with specific patterns of histone modifications 
may prove a useful biomarker in predicting clinical outcomes.  
Histone modifications are reversible in the context of a cancer cell, when compared to 
genetic lesions, making modulators of histone modifying enzymes attractive targets for 
therapeutic interventions in patients with cancer, which have been popularly referred to as 
epigenetic therapies (Ganesan et al., 2009). The epigenetic drugs, such as histone 
deacetylase inhibitors, directed against the altered histone modifications in tumor cells are 
mostly small molecules that have pharmacologic properties that enable easy delivery to 
tumors, which is a sharp contrast with the challenge of delivering gene therapy to reverse 
the effects of genetic silencing (Gunjan and Singh, 2011). Despite the challenge of toxic 
side effects, a number of agents capable of targeting histone modifiers have already 
entered clinical practices and are routinely used in the treatment of specific human 
malignancies (Egger et al., 2004).   
The research on histone modifications is a new and rapidly expanding field holds 
promised to advance our understanding of the key processes underlying tumor 
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development and progression. Better understanding of the mechanism controlling the 
establishment and maintenance of histone marks and how the disruption of these 
mechanisms contribute to tumorigenesis will facilitate the development of novel 
strategies to prevent, diagnose and treat human malignancies. Therefore, future studies on 
histone modifications should greatly impact on many areas of modern biology and will 
help to tailor efficient strategies for cancer therapy and prevention. 
 
1.10 Aim of the study  
To investigate the effects of single point mutation of histones on transcription 
regulation and the relevant protein-protein interactions in Saccharomyces cerevisiae.  
To study the role of histone variant H2A.Z playing in the glucose repression of the 












Chapter 2 Materials and methods 
2.1 Materials  
2.1.1 Yeast Strains  
Genotype of Saccharomyces cerevisiae strains used: 
Strain Genotype Source 
BY4741 MATa; his3Δ 1; leu2Δ 0; met15Δ 0; ura3Δ 0 EUROSCARF 
BY4741W BY4741; TRP1::hisG 
(Chew et al., 
2010) 
BY4741HTZ1 BY4741; YOL012c::kanMX4 EUROSCARF 
BY4741WHTZ1 BY4741HTZ1; TRP1::hisG The present study
BY4742 MATα; his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0 EUROSCARF 
BY4742W BY4742; TRP1::hisG 
(Chew et al., 
2010) 
BY4742HTZ1 BY4742; YOL012c::kanMX4 EUROSCARF 
BY4742WHTZ1 BY4742HTZ1; TRP1::hisG The present study
BY4742TUP1 BY4742; YCR084c::kanMX4 EUROSCARF 
BY4742WTUP1 BY4742TUP1; TRP1::hisG The present study














MATa; his3200; leu2-3,112; lys2-801; 
trp163; ura3-52 
(Dohmen et al., 
1995) 
 
2.1.2 E. coli strains 
For general DNA manipulation: DH5 
For electroporation (higher DNA transformation efficiency): DH10B 
For recombinant protein expression: BL21 
2.1.3 Plasmids 
Plasmid Description Source 
YCplac111-HTA1 
LEU2 marker; single copy; H2A 
expressed under its own promoter; AmpR 
The present study 
Ycplac111-HHF1 
LEU2 marker; single copy; H4 expressed 
under its own promoter; AmpR 
The present study 
PactT316-HA-HTA1 
URA3 marker; single copy; H2A 
expressed under ACT1 promoter; AmpR 
The present study 
Ycplac22-HTA1 
TRP1 marker; single copy; H2A 
expressed under its own promoter, AmpR 
The present study 
pACNX-Nub-HA-X 
LEU2 marker; single copy; protein X 
expressed under ADH1 promoter; ChlR  
(Laser et al., 2000) 
& the present study 
pCup1-Y-CubRura314 
TRP1 marker; single copy; protein Y 
expressed under CUP1 copper-inducible 
promoter; AmpR 
(Laser et al., 2000) 
& the present study 
YEp13  LEU2 maker; multi-copy; AmpR 
(Nasmyth and 





Purpose PCR primer (5’ → 3’) 
YCplac111-HTA1 plasmid construction gccgaattcgaaaatgcggaaagagaa gccgccgtcgactttaccagagaaacgtt 









GAL1(S288C) promoter quantification 
actgctccgaacaataaaga 
atggttgttaatttgattcgttc 
GAL1(BY4742) promoter quantification 
actgctccgaacaataaaga 
atggttgttaatttgattcgtta 
ZDS1 promoter quantification 
acggactcaataacaagtcg 
gacagctaaattctcctttg 
GAL1 ORF and mRNA quantification 
tggttgtactgttcacttgg 
caatgctggtttagagacga 
URA3 ORF and mRNA quantification 
ctctgcgggtgtatacag 
ggagcccttgcatgacaa 
ACT1 mRNA quantification gaccaaactacttacaactcca cattctttcggcaatacctg 
 
2.1.5 Media 
The rich YPDA medium is made of 1% (w/v) Yeast extract (Difco), 2% (w/v) bacto 
Peptone (Difco), 2% (w/v) Dextrose (glucose), and 0.003% Adenine sulfate. The 
synthetic complete (SC) medium contains 0.145% (w/v) yeast nitrogen base without 
amino acid, 2% (w/v) glucose and 0.2% (w/v) of premixed full amino acid powder 
(Sherman, 2002). The SC dropout medium is made just as SC, but the full amino acid 
powder is replaced with one lacking the component covered by the selectable marker. For 
instance, SC-Leu (SC minus Leu) lacks leucine for selection of Leu+ transformants. To 
make solid media, 2% agar (Difco) is added to the YPDA medium or 1.5% agar to SC 
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(dropout) medium.  
 
2.2 Methods 
2.2.1 Construction of histone single-point mutants (for alanine scanning) 
2.2.1.1 Two-step PCR mutagenesis and plasmid construction 
The fragment of wild-type HTA1 (ORF + 500bp) is first cloned into 
YCplac111/YCplac22 plasmid vector using EcoRI/SalI sites. The forward primer (5’-
Phta1-500-EcoRI) and reverse primer (3’-Thta1+500-SalI) were used to generate this 
fragment flank the cloning sites. Then the plasmid is to be used as the template (1 to 500 
dilution of the plasmid isolated from E.coli by miniprep) for the following 2-step PCR. 
The primers containing the point mutation are homologous to the template for 10 bases in 
upstream and downstream of the mutated nucleotides. In two separate reactions, 
fragments upstream and downstream of the point mutation are PCR-amplified using the 
primer containing the point mutation and the flanking primer pairing with it (i.e., the 
forward primer or the reverse primer). The amplified fragments are then purified (High 
Pure PCR Product purification kit, Roche, Cat. No. 11732676001) and used as the 
template for the sequential PCR amplification by the two flanking primers. The full-
length fragment generated here is purified and digested with EcoRI and SalI, subcloned 
into an EcoRI/SalI cut YCplaca111/YCplac22 vector, and transformed into E.coli. The 
resultant plasmid contains an inserted fragment identical to the original DNA except for 
the point mutation. The point mutations are then confirmed by DNA sequencing. All the 
above PCRs are carried out for 25 cycles. 
 
2.2.1.2 Plasmid shuffle 
BY4742WHTA strain containing PactT316-HA-HTA1 is transformed with 
YCplac111/22-HTA1 (WT and mutants) and then counter-selected on FOA plates to 
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generate H2A alanine mutant strains. All the mutant strains are first preserved on YPDA 
plate and then the glycerol stocks of these mutants are generated later (overnight culture 
in YPDA mixed with 50% glycerol by 1:1 v/v ratio). 
 
2.2.2 Phenotypic test (spot assay) 
The procedures of spot assay are carried out as follows: fill each well of a 96-well 
microplate with 90 L sterile water; add same amount of the yeast cells of strains under 
investigation in the wells on the first row (max. 8 samples per row) respectively and 
mixed with water in the wells thoroughly; make 10-fold dilution by removing 10 L yeast 
cell suspension from the first row and pipetting into 90 L water in the well on the second 
row; mix well and repeat this procedure to make a serial dilution till the yeast cell 
suspension in the wells on the sixth row is diluted to the 10-5 of the original suspension on 
the first row; pipette out 5 L cell suspension from each well, and spot on solid media in 
Petri dishes. The procedures are to be done with multichannel pipette when handling 
multiple samples. 
 
2.2.3 Multicopy-suppressor screening 
Histone mutants expressed from YCplac22 vector are transformed with 1g of YEp13 
LEU2-marker yeast genomic library. Transformants (on 3-day plate) are washed off the 
transformation plate and 1% of transformants are plated on the phenotype testing plate to 
screen for suppressors of a particular phenotype of certain histone mutants. Colonies 
growing on the selection plate are picked and re-streaked on the selection plate. Then 
these cells are grown up in liquid media and the plasmids responsible for the suppression 
are isolated, amplified in E.coli, and finally transformed back into respective mutant 
strain to check for plasmid linkage (i.e., to confirm that the suppression of a particular 
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histone mutant phenotype were not caused by the wild-type histone present in the yeast 
genomic library we used). Those potential suppressor plasmids are then sent for 
sequencing and the suppressor candidate genes are identified by blasting in SGD 
(Saccharomyces Genome Database). Selected candidate genes are then subcloned into 
various vectors and subjected to further functionality tests.  
 
2.2.4 Western blotting 
2.2.4.1 Sample preparation 
To prepare crude samples, yeast cell pellet was collected (for 50 ml culture, spin at 
3000 × g for 5 min; for 1 ml culture, spin at 5000 × g for 1 min), and washed with sterile 
water once.  
To prepare protein extract, yeast cell pellet is first collected and washed as described 
above and then resuspended in yeast lysis buffer (the yeast pellet of 1 ml OD. 1 culture is 
to be mixed with 20 l lysis buffer). Glass beads (500 l/ml yeast cell lysis suspension) 
are then added to the cell suspension and yeast cells were homogeninized using a bead 
beater (1 min × 3 times with 1-min interval rest on ice).  
Dilute the sample with equal volume of 2× SDS sample buffer (Laemmli Sample 
buffer, Bio-Rad, Cat. No. 161-0737) and heat 5 min at 95C before loading it on 
acrylamide gel for electrophoresis. 
 
2.2.4.2 SDS discontinuous gel electrophoresis 
Bio-Rad Mini-PROTEAN electrophoresis system is used for polyacrylamide gel casting 
and electrophoresis.  All the procedures conducted are the same as the manufacturer’s 
operating manual. 
 
2.2.4.3 Immunoblotting and immunodetection 
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Proteins separated by SDS-PAGE are electrophoretically transferred to nitrocellulose 
membrane in a semidry transfer apparatus (Trans-Blot SD Semi-Dry Electrophoretic 
Transfer Cell, Bio-Rad, Cat. No. 170-3940). The transfer of proteins to the membrane is 
monitored qualitatively by prestained protein standard (Precision Plus Protein 
Kaleidoscope Standard, Bio-Rad, Cat. No. 161-0375).  
After probing with primary antibody, the antigen-antibody complexes are identified 
with a secondary anti-IgG antibody coupled to a horseradish peroxidase (HRP). The blot 
is then immersed in a luminescent substrate solution (Amersham ECL Plus/advance 
Western blotting detection reagents, GE healthcare, Cat. No. RPN 2132/2135) to visualize 
the enzyme activity. Film contact exposure is used to capture the chemiluminescent signal, 
which typically appears within a few seconds or minutes. 
 
2.2.5 RNA isolation 
QIAGEN RNeasy Mini Kit (Cat. No. 74104) is used for purification of total RNA 
from yeast cells. All the procedures are following the manufacturer’s instructions. The 
integrity of RNA purified is confirmed by FA-gel before being subjected to the 
subsequent DNase treatment. 
Contaminating DNA in the above RNA samples is removed by using DNase 
treatment and removal reagents (DNA-free Kit, Ambion, Cat. No. AM1906). The 
resultant RNA samples are tested for DNA contamination by 40-cycle PCR. Only RNA 
samples that produce no distinctive PCR products are subjected to the subsequent reverse-
transcription PCR. 
 
2.2.6 Quantitative reverse-transcription PCR 
SYBR Green RT-PCR Reagents Kit (including SYBR Green PCR Master Mix and 
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TaqMan Reverse Transcription Reagents, Cat. No. 4310179) is used for the quantitative 
reverse-transcription PCR. All procedures are closely following the manufacturer’s 
protocol. The quantification of mRNA level is carried out in ABI 7000 Sequence 
Detection System.  
 
2.2.7 Chromatin immunoprecipitation 
Yeast cells are grown in SC dropout liquid medium. When its OD600 reaches 1.0, 37% 
formaldehyde (1% final) is added to the culture to cross-link the DNA with the proteins in 
close proximity. 20 min after the cross-linking, glycine is added to stop the reaction. Then 
the cells are harvested and washed 3 times with ice-cold sterile water. Cell pellet is 
resuspended with ice-cold yeast lysis buffer and glass beads are added to the cell 
suspension which is then subjected to the mini bead-beater with a 40 sec × 4 pulse to 
release the chromatin from yeast cells. Chromatin is sheared by a cup horn sonicator () 
with a 30 sec × 10 pulse (Amplitude: 40%) to the size 200-500 bp. Chromatin solution is 
then incubated with antibody-coupled agarose beads overnight. After stringent washes, 
chromatin bound on the beads is eluted at 65C with ChIP elution buffer. The 
immunoprecipitated chromatin is then reverse cross-linked and DNA is isolated by 
ethanol precipitation. Real-time PCR is used to quantitate the relative amount of DNA 
bound by the protein of interest.  
 
2.2.8 GST pull-down assay and immunoprecipitation 
Glutathione Sepharose 4B beads (GE Healthcare, Cat. No. 17-0756-01) is first washed 
and equilibrated in ice-cold yeast lysis buffer (or PBS) for at least half an hour before 
incubation with protein extract. After 2-hour incubation at 4C, glutathione beads are 
washed with yeast lysis buffer (or PBS) for 6 times. GST fusion proteins bound to the 
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beads are eluted with 1× SDS sample buffer at 95C for 5 min before being loaded on the 
SDS-PAGE gel for western blot. 
 
2.2.9 Split-ubiquitin assay  
Plasmids pACNX-Nub-HA-X and pCup1-Y-CubRUra314 (X and Y are referring to 
the proteins of interest) are co-transformed into JD52. The growth of the transformants on 




















Chapter 3 Alanine scanning and phenotypic tests for histone H2A and H4 
3.1 Abstract 
All residues in histone H2A (with the exception of its endogenous alanine and glycine 
residues) were replaced individually with alanine by site-directed mutagenesis. Plasmid-
shuffling was used to exchange wild-type H2A with the H2A single-point mutant proteins 
in yeast cells. Out of the 98 H2A point mutant proteins tested, two (E62A and D91A) 
were unable to complement the HTA1/HTA2 double deletion. Among the resulting 96 
viable H2A mutant strains, one was severely defectively for growth, 12 were sensitive to 
heat, eight were sensitive to antimycin A on galactose plates (indicating defects in the 
transcriptional activation of the GAL genes by Gal4p), three were sensitive to 3-amino 
triazole upon histidine starvation (indicating defects in the transcriptional activation of the 
HIS3 gene by Gcn4p), and one conferred sensitivity to 6-azauracil (indicating defects in 
transcription elongation or in the transcriptional activation of the URA3 gene by Ppr1p). 
Yeast cells expressing 81 point mutant proteins of histone H4 in place of wild-type 
H4 were also tested for phenotypic defects by spot assays. Out of the total 81 H4 point 
mutant proteins, eight were unable to complement the HHF1/HHF2 double deletion; four 
caused growth defects, 19 conferred sensitivity to heat, four caused sensitivity to 
antimycin A on galactose plates, and six caused sensitivity to 3-AT. 
The H2A E57A and H2A R30A mutant proteins, which had caused the gal phenotype 
when expressed in place of wild-type H2A, were found to be defective for the protein 
interaction with Gal4p, the transcriptional activator of the GAL genes. 
 
3.2 Results 
3.2.1 Alanine-scanning mutagenesis and phenotypic analysis of histone H2A 
All residues of histone H2A (with the exception of the alanine and glycine residues) 
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were replaced individually with alanine by site-directed mutagenesis. Plasmid-shuffling 
was used to exchange wild-type H2A with the H2A single-point mutant proteins 
expressed from single-copy vectors under the control of the endogenous H2A promoter 
and terminator. Figure 3.1 shows that the H2A point mutant proteins E62A and D91A 
were unable to complement the HTA1/HTA2 double deletion strain. Cells representing 
each viable histone H2A point mutant strain were taken from the FOA plates and tested 
for other phenotypic defects.  
Eight histone H2A mutant strains (F26A, R30A, E57A, L86A, E93A, L94A, I112A 
and L116A) were sensitive to antimycin A on galactose plates (Figure 3.2, lines 3, 4, 5, 14, 
15, 16, 19, 21), with the H2A-I112A mutant strain displaying the most severe phenotype 
(Figure 3.2, line 19). Sensitivity to antimycin A on galactose plates indicates that the 
respective mutant strains were defective for the transcriptional activation of the GAL 
genes by Gal4p (Figure 3.2, line 1). 
Three H2A mutant strains (N74A, E93A and I112A) were sensitive to 3-AT on 
histidine-depleted plates (Figure 3.3), indicating that they were defective for the 
transcriptional activation of the HIS3 gene by Gcn4p (Figure 3.3, line 3). 
Sensitivity to 6-AU may reflect defects in transcription elongation or defects in the 
transcriptional activation of the URA3 gene by Ppr1p (Figure 3.4, line 1). In vitro, 
transcription elongation by RNA polymerase II is facilitated by the removal of the H2A-
H2B dimers from the nucleosome template (Belotserkovskaya et al., 2003), suggesting 
that mutations in the interface between the H2A-H2B dimers and DNA or the (H3-H4)2 
tetramer affect transcription elongation. The H2A E57A mutant strain was sensitive to 6-
AU on uracil-depleted plates (Figure 3.4, line 10), indicating that it was defective for 




Figure 3.1 Growth defects and temperature sensitivity of cells expressing histone 
H2A alanine point mutant proteins in place of wild-type H2A 
Cells transformed with the single-copy LEU2-marked vector YCplac111 expressing H2A 
with the indicated alanine point mutations from its endogenous promoter and terminator 
were tenfold serially diluted, spotted onto leucine-depleted plates (L) and FOA plates 
(FOA) and incubated at 28C for 3 days or at 38C for 6 days. Line 1 served as a negative 
control, showing that H2A is essential for cell survival. Line 2 served as a positive control, 
showing that wild-type H2A expressed from YCplac111 under the control of its own 
promoter and terminator is fully functional. Cells displaying reduced growth at 38C were 
considered temperature sensitive. 
Out of the 98 H2A point mutant proteins, two (E62A and D91A) failed to complement the 
HTA1/HTA2 double deletion. Among the remaining 96 point mutant proteins, one (Y58A) 
caused a severe growth defect and 12 (F26A, R30A, E57A, E65A, L66A, D73A, K76A, 
R78A, L86A, I103A, I112A and L116A) conferred heat sensitivity. Shown is only a 





Figure 3.2 Antimycin A sensitivity of histone H2A alanine point mutant strains 
Cells expressing the indicated H2A alanine point mutant proteins from the LEU2-marked 
single-copy vector YCplac111 under the control of the endogenous H2A promoter and 
terminator in place of wild-type H2A were tenfold serially diluted, spotted onto leucine-
depleted glucose plates (L), leucine-depleted galactose plates containing 0.1 mg/L 
antimycin A (Gal + 0.1 AA) and leucine-depleted galactose plates containing 1.0 mg/L 
antimycin A (Gal + 1.0 AA) and incubated at 28C for 3 days (L) or 6 days (Gal + 0.1AA 
and Gal + 1.0 AA). Line 1 served as a negative control, showing the gal phenotype 
(antimycin sensitivity) of the GAL4 gene deletion strain. Line 2 served as a positive 
control, showing that cells expressing wild-type H2A under the control of its own 
promoter and terminator from the LEU2-marked single-copy vector YCplac111 are 
resistant to antimycin A, i.e., fully functional for the transcriptional activation of the GAL 
genes by Gal4p. Eight H2A mutant strains (F26A, R30A, E57A, L86A, E93A, L94A, 
I112A and L116A) were sensitive to antimycin A on galactose plates, with the H2A-








Figure 3.3 3-Aminotriazole sensitivity of histone H2A alanine point mutant strains 
Cells expressing the indicated H2A alanine point mutant proteins from the TRP1-marked 
single-copy vector YCplac22 under the control of the endogenous H2A promoter and 
terminator in place of wild-type H2A were tenfold serially diluted, spotted onto histidine-
depleted plates (H), histidine-depleted plates containing 5 mM 3-AT (H + 5 AT) and 
histidine-depleted plates containing 50 mM 3-AT (H + 50 AT) and incubated at 28C for 3 
days. Line 3 served as negative control, showing the 3-AT sensitivity of the GCN4 gene 
deletion strain. Lines 1 and 2 served as a positive control, showing that cells expressing 
wild-type H2A from the TRP1-marked single-copy vector YCplac22 are resistant to 3-AT, 
i.e., fully functional for the transcriptional activation of the HIS3 gene by Gcn4p. Three 
H2A mutant strains (N74A, E93A and I112A) were sensitive to 3-AT on histidine-













                                                                                
Figure 3.4 6-Azauracil sensitivity of histone H2A alanine point mutant strains  
The indicated H2A alanine point mutant strains were tenfold serially diluted, spotted onto 
uracil-depleted plates (U) and uracil-depleted plates containing 10 mg/L 6-AU and 
incubated at 28C for 3 days. Line 1 served as a negative control, showing the 6-AU 
sensitivity of the PPR1 gene deletion strain. Line 2 served as a positive control, showing 
that cells expressing wild-type H2A under the control of its own promoter from 
YCplac111 are resistant to 6-AU, i.e., fully functional for the transcriptional activation of 
the URA3 genes by Ppr1p and transcriptional elongation. The H2A E57A mutant strain 





3.2.2 Alanine-scanning mutagenesis and phenotypic analysis of histone H4 
All residues of histone H4 (with the exception of the alanine and glycine residues) 
were replaced individually with alanine by site-directed mutagenesis. Plasmid-shuffling 
was used to exchange wild-type H4 with the H4 single-point mutant proteins expressed 
from single-copy vectors under the control of the endogenous H4 promoter and terminator. 
Figure 3.5 shows that eight H4 alanine point mutant proteins were unable to complement 
the HHF1/HHF2 double deletion (R40A, R45A, R55A, F61A, Y72A, H75A, K79A and 
V87A), four caused growth defects (I34A, R78A, L90A and Y98A), and 24 displayed 
sensitivity to heat (N25A, I34A, R35A, R36A, L37A, K44A, I46A, I50A, Y51A, E53A, 
L62A, I66A, V70A, T73A, E74A, R78A, T80A, L84A, V86A, L90A, K91A, R92A, 
L97A and Y98A). Cells representing each viable histone H4 point mutant strain were 
taken from the FOA plates and tested for other phenotypic defects. 
Four H4 mutant strains (T73A, R78A, L97A and Y98A) were sensitive to antimycin 
A on galactose plates, with the H4 Y98A mutant strain displaying the most severe 
phenotype (Figure 3.6, line 15). The inability of the cells to grow on galactose plates in 
the presence of the respiration inhibitor antimycin A indicates defects in the 
transcriptional activation of the GAL genes by Gal4p (Figure 3.6, line 1). Four H4 mutant 
strains (I34A, R78A, K91A and Y98A) were sensitive to 3-AT on histidine-depleted 
plates (Figure 3.7, lines 5, 15, 20, 24), indicating defects in transcriptional activation of 
the HIS3 gene by Gcn4p (Figure 3.7, line 2). The results of the alanine-scanning 
mutagenesis and phenotypic testing of histones H2A and H4 are summarized in Figures 











Figure 3.5 Growth defects and temperature sensitivity of cells expressing histone H4 
alanine mutant proteins in place of wild-type H4 
Cells transformed with the single-copy LEU2-marked vector YCplac111 expressing H4 
with the indicated alanine point mutations from its endogenous promoter and terminator 
were tenfold serially diluted, spotted onto leucine-depleted plates (L) and FOA plates 
(FOA) and incubated at 28C for 3 days or at 38C for 6 days. Line 1 served as a negative 
control, showing that histone H4 is essential for cell survival. Line 2 served as a positive 
control, showing that wild-type H4 expressed under the control of its own promoter and 
terminator from the LEU2-marked single-copy vector YCplac111 is fully functional. Cells 
displaying growth defects at 38C were deemed as temperature sensitive. 
Out of the 81 histone H4 point mutant proteins, eight were unable to complement the 
HHF1/HHF2 double deletion (R40A, R45A, R55A, F61A, Y72A, H75A, K79A and 
V87A), four caused growth defects (I34A, R78A, L90A and Y98A), and 24 displayed 
sensitivity to heat (N25A, I34A, R35A, R36A, L37A, K44A, I46A, I50A, Y51A, E53A, 
L62A, I66A, V70A, T73A, E74A, R78A, T80A, L84A, V86A, L90A, R92A, K91A, 
















Figure 3.6 Antimycin A sensitivity of histone H4 alanine point mutant strains 
Cells expressing the indicated H4 alanine point mutant proteins from the LEU2-marked 
single-copy vector YCplac111 under the control of its own promoter and terminator in 
place of wild-type H4 were tenfold serially diluted, spotted onto leucine-depleted glucose 
plates (L), leucine-depleted galactose plates containing 0.1 mg/L antimycin A (Gal + 0.1 
AA) and leucine-depleted galactose plates containing 1.0 mg/L antimycin A (Gal + 1.0 
AA), and incubated at 28C for 3 days (L) or 6 days (Gal + 0.1AA and Gal + 1.0 AA). 
Line 1 served as negative control, showing the gal phenotype (antimycin sensitivity) of 
the GAL4 gene deletion strain. Line 2 served as positive control, showing that the cells 
expressing wild-type H4 under the control of its own promoter and terminator from the 
LEU2-marked single-copy vector YCplac111 are resistant to antimycin A, i.e., fully 
functional for the transcriptional activation of the GAL genes by Gal4p. Four H4 mutant 
proteins (T73A, R78A, L97A and Y98A) caused sensitivity to antimycin A on galactose 
plates, with the H4 Y98A mutant strain displaying the most severe phenotype. Shown is 












Figure 3.7 3-Aminotriazole sensitivity of histone H4 alanine point mutant strains 
Cells expressing the indicated H4 alanine point mutant proteins from the LEU2-marked 
single-copy vector YCplac111 under the control of its own promoter and terminator in 
place of wild-type H4 were tenfold serially diluted, spotted onto histidine-depleted plates 
(H), histidine-depleted plates containing 5 mM 3-AT (H + 5 AT) and histidine-depleted 
plates containing 50 mM 3-AT (H + 50 AT), and incubated at 28C for 3 days. Line 2 
served as negative control, showing the 3-amino triazole sensitivity of the GCN4 gene 
deletion strain. Line 1 served as positive control, showing that cells expressing wild-type 
H4 under the control of its own promoter and terminator from the LEU2-marked single-
copy vector YCplac111 are resistant to 3-amino triazole, i.e., fully functional for the 
transcriptional activation of the HIS3 genes by Gcn4p. Four H4 mutant strains (I34A, 
R78A, K91A and Y98A) were sensitive to 3-AT on histidine-depleted plates, indicating 
defects in transcriptional activation of the HIS3 gene by Gcn4p. Shown is only a subset of 
the performed titrations. 
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Figure 3.8 Summary of phenotypes displayed by histone H2A mutants                                                                                                                             
The positions of the mutations causing the depicted phenotypic defects are indicated by filled blocks, and the residues that are required for viability are 
blocked out. The -helices and loops located within the structured regions are labeled, and the flexible histone tails are indicated by dashed lines.  
 
 
Figure  3.9 Summary of phenotypes displayed by histone H4 mutants  
The positions of the mutations causing the depicted phenotypic defects are indicated by filled blocks, and residues that are required for viability are 
blocked out. The -helices and loops located within the structured regions are labeled, and the flexible histone tails are indicated by dashed lines.  
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3.2.3 The H2A mutations R30A and E57A weakened the interaction with Gal4p and 
caused the gal phenotype 
The split-ubiquitin system was used to identify proteins whose interaction with 
histones was affected by those alanine mutations that had caused phenotypic defects. 
Figure 3.10, line 1, shows that cells co-expressing Nub and Gal4-Cub-RUra3p were able to 
grow on plates lacking uracil, indicating that the Gal4-Cub-RUra3p fusion was 
enzymatically functional. Cells co-expressing Nub-H2A and Gal4-Cub-RUra3p were 
unable to grow on plates lacking uracil (line 2), indicating that H2A and Gal4p interacted 
inside the cell, bringing Nub and Cub together and causing the cleavage and degradation of 
the RUra3p part of the fusion. Cells co-expressing Nub-H2A E57A and Gal4-Cub-RUra3p 
were able to grow on plates lacking uracil (line 4), indicating that H2A E57 was required 
for the protein-protein interaction with Gal4p. The Gal4-Cub-RUra3p fusion was 
expressed from a single-copy vector under the control of the CUP1 promoter, which 
allows for an increase in protein expression by the addition of CuSO4. Cells co-expressing 
Nub-H2A R30A and Gal4-Cub-RUra3p were able to grow on CuSO4-containing plates 
lacking uracil (line 3), indicating that H2A R30 was also required for the protein-protein 
interaction with Gal4p, albeit to a lesser degree than E57. Consistently, the H2A E57A 
mutant strain had displayed a stronger gal phenotype than the H2A R30A mutant strain 









Figure 3.10 H2A R30A and H2A E57A mutant strains were defective for the protein-
protein  interaction with Gal4p 
Yeast cells expressing the indicated combinations of split-ubiquitin fusions were tenfold 
serially diluted, spotted onto the depicted plates and incubated for three days at 28ºC. The 
plate lacking tryptophan and leucine (WL) indicates the number of cells containing both 
the Nub and the Cub fusion plasmids. Protein-protein interaction is indicated by the lack of 
growth on the plate lacking uracil, tryptophan and leucine (UWL) and on the UWL plate 
containing 100mM CuSO4 (100UWL). CuSO4 served to increase the expression level of 
Gal4-Cub-RUra3p, which was expressed under the control of the CUP1 promoter. 
 
3.3 Discussion 
Histones are highly conserved and have multiple functional and structural domains 
and motifs. N-terminal and C-terminal deletion mutagenesis has been used for domain-
based functional analysis of histones by a previous postgraduate student in our lab (He, 
2008). However, if the deleted region is required for the preservation of tertiary structure, 
it is difficult to assess the functional status of the mutant histone. Another approach which 
has been undertaken for the identification and characterization of functional proteins is 
site-directed point mutagenesis (Smith, 1985). As it has only subtle effects on protein 
structure (Muthurajan et al., 2004), it would be expected that only few histone point 
mutants would stand out in various phenotypic tests.  
Core histones serve as the central hub among nuclear proteins, and each histone 
residue is potentially playing important roles in interacting with other nuclear proteins 
which are involved in regulating a variety of DNA-mediated reactions, such as 
nucleosome assembly and transcription. The residues of core histones in nucleosomes can 
be categorized into two groups by their positions. The first group includes residues that 
are on exposed nucleosomal surfaces involved in primary interactions with chromatin 
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factors, which directly initiate DNA-mediated reactions. The second group includes 
residues that are located in buried histone domains and involved in histone-histone and 
histone-DNA interactions. Therefore, the analysis of every residue of core histones by a 
comprehensive point mutagenesis would help us to understand the molecular mechanisms 
of nuclear processes regulated by the interactions between chromatin factors and core 
histones. 
This study started with histone H2A by constructing a comprehensive alanine-
scanning library, composed of 98 H2A point mutants, and found a number of H2A point 
mutant proteins that conferred lethality / slow growth, and sensitivity to high temperature, 
antimycin A, 3-aminotriazole, and 6-azauracil. The well-characterized assay systems 
adopted here are often used to monitor phenotypes in genetic analyses of transcription 
initiation / elongation. 
The functional integration of H2A in the nucleosome theoretically relies on four 
distinct interactions: one H2A-DNA interaction and four histone-histone interactions: 
H2A-H2A, H2A-H2B, H2A-H3, and H2A-H4. The H2A point mutant proteins Y58A, 
E62A and D91A were unable to complement the HTA1/HTA2 double deletion or caused 
slow growth, respectively. H2A Y58 and H2A E62 are essential exposed residues, 
interacting with H2B L109 together with an exposed non-essential residue, H2A E93 
(Matsubara et al., 2007). These three H2A residues are located at the acidic patch, which 
consists of a cluster of acidic amino acids on the nucleosome surface, and serves as 
binding sites for the basic N-terminal tail of H4 (Luger et al., 1997). Histone chaperon 
Chz1 interacts with the acidic patch of histone variant H2A.Z (Zhou et al., 2008), whose 
acidic patch is highly homologous to that of canonical H2A. In addition, methylation of 
H3 K4 is abolished by several histone point mutations located at the acidic patch 
(Nakanishi et al., 2008), suggesting that the acidic patch is likely to serve as target site for 
various chromatin factors. 
60 
 
White and colleagues (2001) pointed out that the extremely well-ordered C-terminal 
helix of H2B lies exposed on the surface of the histone octamer, and is involved in 
forming essential crystal contacts in the yeast nucleosome (White et al., 2001). H52 on 
the L1 loop of H2B and E65 on the 2 helix of H2A, together with another histidine 
residue and glutamate residue from the neighboring nucleosomes chelate a manganese ion. 
The authors emphasize that the involvement of these residues in in vivo nucleosome 
packing is not supported by any experimental evidence at that time. In our experimental 
set-up, the H2A E65A mutant strain displays temperature sensitivity (Figure 3.1, line 8), 
which could serve as an indirect evidence of this hypothesis. In turn, their hypothesis 
could provide a possible explanation for the TS phenotype displayed by the H2A E65A 
mutant strain. In addition, other H2A mutant strains adjacent to E65 (E62A and L66A) 
also displayed growth defects and temperature sensitivity (Figure 3.1, lines 7 and 9), 
indicating the possible involvement of these residues in the internucleosomal interaction 
between H2A and H2B.  
The main step in nucleosome disassembly is dissociation of the H2A-H2B dimers and 
the (H3-H4)2 tetramer from surrounding DNA. There are 20 amino acids involved in the 
interactions between the H2A-H2B dimer and the DNA (for H2A, residue R30, R33, R36, 
R37, R43, K75 and R78 are involved), while 29 amino acids are involved in the H3-H4 
dimer-DNA interaction (for H4, residue K44, R45, S47, T73, K77, R78, T80, T82 and 
T96 are involved) (White et al., 2001). The 2009 paper of Sakamoto and colleagues 
proposed that H2A R78, H4 R36, H4 R45 are functional key residues in regulating 
histone-DNA interactions in a variety of DNA-mediated reactions. Key regions of core 
histones involved in histone-DNA interactions were also mapped by an in vitro approach 
(Sakamoto et al., 2009). H2A R30 and H4 R35, R36, R45 and G48 are located at the 
proposed key regions. 
It has been reported that the residues of calf thymus core histones which correspond 
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to yeast H2A R78 and H4 R45 are potentially modified (Zhang et al., 2003). Chemical 
modifications of core histones, such as ubiquitination of H2B K123, acetylation of H3 
K56, methylation of H3 K79, and acetylation of H4 K91 have been reported to regulate 
their functional activities in yeast (Feng et al., 2002; Masumoto et al., 2005; Ng et al., 
2002; Xu et al., 2005; Ye et al., 2005), but not all of them interact with DNA. 
The H2A residues I112, H113 and L116 are involved in the H2A-H3 interaction, and 
cells expressing the H2A I112A mutant protein in place of wild-type H2A were sensitive 
for all phenotypes tested. For H4, the Y98A mutant strain displayed severe growth defects 
on all plates tested, indicating that these mutant strains could be generally defective for 
the activation of transcription. 
H2A I112A is located at a region called the docking domain (Luger et al., 1997). H2A 
H113A is reported to confer sensitivity to 6-AU (Matsubara et al., 2007). FACT 
(facilitates chromatin transcription) complex was shown to remove the H2A-H2B dimer 
from the nucleosome during transcription elongation (Belotserkovskaya et al., 2003). It 
seems that FACT functionally interacts with the docking domain and to facilitate the 
release of H2A from the nucleosome through destabilizing its interaction with H3.The 
H2A I103 and L116 residues are involved in the physical interaction with H4 (Luger et al., 
1997). 
Others studies have shown that many histone residues are specifically responsible for 
the Spt- phenotype or for sensitivity to the DNA-damaging agent MMS (Matsubara et al., 
2007), suggesting that transcription initiation and DNA repair mainly use different 
nucleosome surfaces as well as different buried surfaces. Our strategy is one way to 
understand the functional roles of each residue of evolutionarily conserved core histones 
in a variety of DNA-mediated reactions including transcription initiation, repression and 
elongation at the single amino acid level. 
The split-ubiquitin assay revealed that histone H2A interacted with Gal4p, which is 
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the transcriptional activator of the GAL genes (Figure 3.10, compare lines 1 and 2). The 
assay further demonstrated that the H2A R30A and H2A E57A mutant proteins were 
defective for this protein-protein interaction, with the E57A mutation causing the more 
severe defect (Figure 3.10, compare lines 3 and 4). Both mutant histone H2A proteins had 
caused the gal phenotype when expressed in place of wild-type H2A, and consistently  
H2A E57A had caused the more severe gal phenotype as compared to H2A R30A (Figure 
3.2, compare lines 4 and 5). The H2A E57A mutation increases the net positive charge of 
histone H2A, and it is possible that Gal4p fails to bind to its sites in the enhancers of the 
GAL genes if they are compacted within nucleosomes containing the H2A E57A mutant 
protein. Chromatin immunoprecipitation with antibody against Gal4p could be used to 















Chapter 4 Investigation of the glucose repression defective phenotype of histone 
mutants 
4.1 Abstract 
Histones play an important role in the activation as well as in the repression of 
transcription, and I screened the library of histone mutants in order to identify residues 
that are required for glucose repression of the GAL1 promoter. Multi-copy suppressors for 
the glucose repression defective histone mutants were isolated, however, none of them 
revealed a possible mechanism by which those histone residues could be involved in 
glucose repression. The Split-Ubiquitin assay showed that the histone H4 K91A mutant 
protein, which caused a glucose repression defect, was also defective for the protein-
protein interaction with the core histones H2A, H2B and H4, indicating that nucleosomes 
that contain the H4 K91A mutant protein are less stable than wild-type nucleosomes. H4 
K91 is subject to acetylation; however, glucose repression of the GAL1 promoter was 
intact in the H4 K91R mutant and deficient in the H4 K91Q mutant. The H4 K91R 
mutant resembles un-modified H4 K91, while the H4 K91Q mutant mimics acetylated H4 
K91, and the results indicate that H4 K91 de-acetylation, rather than acetylation, might be 
important for the glucose repression of the GAL1 promoter. Testing of a collection of 
HDAC gene deletion strains revealed that only the SIN3 strain was defective for glucose 
repression of the GAL1 promoter, indicating that the Sin3-Rpd3 HDAC complex could 
potentially be responsible for the deacetylation of H4 K91ac. 
 
4.2 Results
4.2.1 Glucose repression defective histone mutants 
The single-copy LYS2-marked plasmid Pgal1-URA317 that expresses Ura3p under 
the control of the GAL1 promoter was used to test the histone mutant strains for defects in 
glucose repression. Cells expressing Ura3p are unable to grow on plates containing FOA, 
since Ura3p, ornithine-5-phosphate decarboxylase, converts FOA into toxic fluoro uracil. 
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Wild-type cells containing the Pgal1-URA317 plasmid are able to grow on lysine-
depleted FOA glucose plates, as glucose represses the GAL1 promoter and prevents the 
expression of Ura3p. Reduction of growth on glucose FOA plates was observed for cells 
expressing the histone mutant proteins H2A I79A, H3 D123A, H4 N25A, H4 Y51A, H4 





Figure  4.1 Histone mutant strains defective for glucose repression 
Histone mutant strains transformed with the single-copy LYS2-marked vector Pgal1-
URA317 that expresses Ura3 under the control of the GAL1 promoter were tenfold 
serially diluted and spotted onto glucose control plates lacking lysine (K) and onto 
glucose FOA plates lacking lysine (K-FOA). The plates were incubated for six days at 
28ºC. Defects in glucose repression are indicated by the lack of growth on the FOA plate. 
 
4.2.2 Suppressor screening 
Glucose repression defective histone mutant strains containing the Pgal1-URA317 
plasmid were transformed with the YEp13 multi-copy library (Nasmyth and Reed, 1980). 
In order to give the suppressors time to re-establish glucose repression and prevent the 
expression of Ura3p, the transformants were at first spread onto glucose plates lacking 
leucine, lysine and tryptophan (which selects for YCplac22, the single-copy vector 
expressing the histone mutant proteins). After incubation at 28ºC for three days, the cells 
were washed off the plate and an aliquot of 1% was spread onto glucose FOA plates 
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lacking leucine, lysine and tryptophan for suppressor screening. Colonies were grown in 
liquid media and the respective YEp13 plasmids were isolated from them. The isolated 
YEp13 plasmids were then amplified in E.coli and transformed back into the mutant 
strains to test for plasmid linkage (Figures 4.2 and 4.3). Confirmed suppressor plasmids 
were sequenced. The suppressor screen is summarized in Table 4.1. 
 
Table 4.1 Screen for suppressors of glucose repression defective histone mutants 
The table indicates the histone mutants, the number of primary transformants on the 
glucose plates lacking lysine, tryptophan and leucine, as well as the number of colonies 
picked from the glucose FOA plate lacking lysine, tryptophan and leucine (KWL-FOA). 
“High background” indicates that there were too many colonies to pick from the 
respective plates. 
 
Figure 4.2 Multi-copy suppressors of the glucose repression defect caused by H4 
N25A 
Tenfold serial dilutions of H4 N25A cells containing Pgal1-URA317 plasmid were 
spotted onto glucose plates lacking lysine, tryptophan and leucine (KWL) and onto 
glucose FOA plates lacking lysine, tryptophan and leucine (KWL-FOA). Cells in line 1 
contain the empty LEU2-marked multi-copy vector YEplac181, cells in line 2 express 
wild-type H4 from the LEU2-marked single-copy vector YCplac111, and cells in lines 3 
to 8 contain the indicated YEp13 suppressor plasmid. Intact glucose repression is 








H4 (N25A) 4 
H4 (Y51A) 5 
H4 (E53A) high background 




Figure 4.3 Multi-copy suppressors of the glucose repression defect caused by H4 
K91A 
Tenfold serial dilutions of H4 K91A cells containing Pgal1-URA317 plasmid were 
spotted onto glucose plates lacking lysine, tryptophan and leucine (KWL) and onto 
glucose FOA plates lacking lysine, tryptophan and leucine (KWL-FOA). Cells in line 1 
contain the empty LEU2-marked multi-copy vector YEplac181, cells in line 2 express 
wild-type H4 from the LEU2-marked single-copy vector YCplac111, and cells in lines 3 
to 22 contain the indicated YEp13 suppressor plasmid. Intact glucose repression is 





The plasmid-linked multi-copy suppressor plasmids were sequenced. YEp13-
Sh4N25A#1 contained CCZ1, OPY1, SHE3 and ATG14, while YEp13-Sh4N25A#4 
contained RNR1, VTC1, ALD5, RPS24A and YOS1. YEp13-Sh4K91A#3, #6, #12 #19 
contained CHO1, GAL83 and MIG3, while YEp13-Sh4K91A#11, #15 contained 
YKL171W, MRPL38, KKQ8 and MRP49. Table 4.2 summarizes the functions of these 
genes. 
Suppressor plasmid Gene Gene function (Cherry et al.) 
YEp13-Sh4N25A 1a 
CCZ1 
Protein involved in vacuolar assembly, essential 
for autophagy and the cytoplasm-to-vacuole 
pathway. 
OPY1 
Protein of unknown function, overproduction 
blocks cell cycle arrest in the presence of mating 
pheromone; the authentic, non-tagged protein is 
detected in highly purified mitochondria in high-
throughput studies. 
SHE3 
Protein that acts as an adaptor between Myo4p and 
the She2p-mRNA complex; part of the mRNA 
localization machinery that restricts accumulation 
of certain proteins to the bud; also required for 
cortical ER inheritance. 
ATG14 
Autophagy-specific subunit of phosphatidylinositol 
3-kinase complex I; Atg14p targets complex I to 
the phagophore assembly site (PAS); required for 
localizing additional ATG proteins to the PAS; 
homolog of human Barkor. 
YEp13-Sh4N25A 4a 
RNR1 
One of two large regulatory subunits of 
ribonucleotide-diphosphate reductase; the RNR 
complex catalyzes rate-limiting step in dNTP 
synthesis, regulated by DNA replication and DNA 
damage checkpoint pathways via localization of 
small subunits. 
VTC1 
Vacuolar transporter chaperon (VTC) involved in 
distributing V-ATPase and other membrane 
proteins; together with other VTC proteins, forms a 
heterotetrameric complex that associates with the 
SNARE Nyv1p and the V0 sector of the V-ATPase. 
ALD5 
Mitochondrial aldehyde dehydrogenase, involved 
in regulation or biosynthesis of electron transport 
chain components and acetate formation; activated 
by K+; utilizes NADP+ as the preferred coenzyme; 
constitutively expressed. 
RPS24A 
Protein component of the small (40S) ribosomal 
subunit; identical to Rps24Bp and has similarity to 
rat S24 ribosomal protein. 
YOS1 
Integral membrane protein required for ER to 
Golgi transport; localized to the Golgi, the ER, and 




Table 4.2 Genes located on the YEp13 that suppressed the glucose repression defect 
caused by H4 N25A and H4 K91A 
 
 
4.2.3 Interactions of histone H4 with other histones are weakened by the H4 K91A 
mutation 
The split-ubiquitin assay was used to determine the effect of the H4 K91A mutation 
on the protein-protein interaction of histone H4 with each of the four core histones. Cells 
co-expressing Nub and H2A-Cub-RUra3 grew on plates lacking uracil and were unable to 
grow on plates containing FOA (Figure 4.4, line 1), indicating that the H2A-Cub-RUra3 
fusion was enzymatically functional. Cells co-expressing Nub-H4 and H2A-Cub-RUra3 
were unable to grow on the plate lacking uracil and grew on the FOA plate (Figure 4.4, 
line 2), reflecting the protein-protein interaction between H4 and H2A. Exchanging lysine 
91 with alanine in Nub-H4 increased growth on the plate lacking uracil and reduced 
growth on the FOA plate (Figure 4.4, line 3), indicating that the H4 K91A mutation 







Phosphatidylserine synthase, functions in 
phospholipid biosynthesis; transcriptionally 
repressed by myo-inositol and choline. 
GAL83 
One of three possible beta-subunits of the Snf1 
kinase complex, allows nuclear localization of the 
Snf1 kinase complex in the presence of a 
nonfermentable carbon source; contains glycogen-
binding domain. 
MIG3 
Probable transcriptional repressor involved in 
response to toxic agents such as hydroxyurea that 
inhibit ribonucleotide reductase; phosphorylation 
by Snf1p or the Mec1p pathway inactivates Mig3p, 





Putative protein of unknown functions; predicted 
protein kinase; implicated in proteasome function; 
epitope-tagged protein localizes to the cytoplasm. 
MRPL38 
Mitochondrial ribosomal protein of the large 
subunit; appears as two protein spots (YmL34 and 
YmL38) on two-dimensional SDS gels. 
KKQ8 Putative serine/threonine protein kinase with unknown cellular role. 
MRP49 Mitochondrial ribosomal protein of the large subunit, not essential for mitochondrial translation. 
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revealed that the H4 K91A mutation weakened the interaction of H4 with H2B (Figure 
4.4, compare lines 4 to 6) and, to a lesser extent, the interaction of H4 with itself (Figure 
4.4, compare lines 10 to 12), while the interaction of H4 with H3 was not affected 
significantly (Figure 4.4, compare lines 7 to 9). 
 
Figure 4.4 The H4 K91A mutation reduced the protein interactions with the four 
core histones 
Yeast cells expressing the indicated combinations of split-ubiquitin fusions were tenfold 
serially diluted, spotted onto the depicted plates and incubated for three days at 28ºC. The 
plate lacking tryptophan and leucine (WL) indicates the number of cells containing both 
the Nub and the Cub fusion plasmids. Protein-protein interaction is indicated by the lack 
of growth on the plate lacking uracil, tryptophan and leucine (UWL) and by growth on 
the FOA plate lacking tryptophan and leucine (FWL). 
 
4.2.4 H4 K91Q, but not H4 K91R, caused a glucose repression defect 
Newly synthesized histone H4 is acetylated on K91, which is a residue that lies at the 
interface of the histone H2A/H2B dimer and the H3/H4 tetramer (Ye et al., 2005). In 
order to determine if this modification plays a role in glucose repression of the GAL1 
promoter, strains expressing the H4 K91R and the H4 K91Q mutant proteins in place of 
wild-type H4 were generated by site-directed mutagenesis and plasmid shuffle. Glucose 
repression of the GAL1 promoter was intact in the strain expressing the H4 K91R mutant 
protein, while it was defective in the strain expressing the H4 K91Q mutant protein 
(Figure 4.5, upper panel). H4 K91R resembles H4 that is not acetylated at K91, while H4 
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K91Q mimics H4 that is acetylated at K91. The results indicate that glucose repression of 
the GAL1 promoter requires the positive charge of unmodified H4 K91. 
The H4 K91A mutant strain had also been defective for the transcriptional activation 
of the HIS3 gene by Gcn4p (Figure 3.6, line 62). Figure 4.5 shows that the H4 K91Q 
mutant strain, but not the H4 K91R mutant strain, was sensitive to histidine starvation, 
indicating that transcriptional activation of the HIS3 gene by Gcn4p also requires the 
positive charge of unmodified H4 K91. 
 
Figure 4.5 The role of H4 K91 in transcriptional regulation 
Tenfold serial dilutions of Pgal1-URA317-containing cells that expressed the indicated H4 allele 
were spotted onto the depicted plates and incubated for three days at 28ºC. Glucose repression 
defects are revealed by growth on the FOA plate (upper panel).  
Tenfold dilutions of cells expressing the indicated H4 allele were spotted onto the depicted plates 
and incubated for three days at 28ºC. Defects in the transcriptional activation of the HIS3 gene are 





4.2.5 Glucose repression defects of HDAC gene deletion strains 
Previously, it has been speculated that the positive charge of H4 K91 might be 
important for formation of the histone octamer, as the acetylation of H4 K91 might 
prevent premature interactions between the dimer and tetramer subunits of the 
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nucleosome during chromatin assembly (Ransom et al.; Ye et al., 2005). The results 
presented in the previous section indicate that the deacetylation at H4 K91 might be 
important for proper glucose repression. To find out the potential HDAC responsible for 
the deacetylation at H4 K91, a series of HDAC gene deletion strains were tested. Out of 
the 20 HDAC deletion strains tested, only the SIN3 strain showed defects in glucose 
repression, suggesting a possible involvement of the Sin3p-Rpd3 histone deacetylase 













































Figure 4.6 Glucose repression defects of HDAC gene deletion strains 
BY4742 cells lacking the gene encoding the indicated HDAC were tenfold serially 
diluted and spotted onto glucose plates lacking lysine (K) and onto glucose FOA plates 









Histones are important regulators of transcription, as they regulate access of the 
transcription machinery to the DNA. In this chapter, several core histone residues that are 
required for the glucose repression of the GAL1 promoter were identified. Suppressor 
screens were performed, but the identified suppressors did not really reveal any 
mechanisms of repression that those residues could be involved in. The Split-Ubiquitin 
system, on the other hand, demonstrated that the H4 K91A mutant protein, which caused 
a glucose repression defect, was also defective for the interaction with the core histones 
H2A and H2B. This indicated that nucleosomes that contain the H4 K91A mutant protein 
are less stable than wild-type histones, providing support for the hypothesis that stable 
nucleosomes prevent transcription. 
The H4 K91 residue is subject to acetylation, indicating that H4 K91 acetylation 
might be important for glucose repression. However, the H4 K91R mutant protein, which 
cannot be acetylated, did not cause any defects in glucose repression; whereas the H4 
K91Q mutant protein, which resembles the acetylated H4 K91, was defective for glucose 
repression. This indicated that the deacetylation of H4 K91 rather than its acetylation 
could be required for glucose repression. Chromatin immunoprecipitation with an 
antibody specific for acetylated H4 K91 will have to be performed in the future to 
confirm this hypothesis. A collection of HDAC gene deletion strains revealed that cells 
lacking Sin3p were defective for glucose repression, indicating that the Sin3-Rpd3 
complex could play a role in the deacetylation at H4 K91. Chromatin 
immunoprecipitation with an antibody against Sin3p and in vitro deacetylation assays will 







Chapter 5 Investigation of the interactions between histones and Mig proteins  
5.1 Abstract 
Mig1p establishes glucose repression of the GAL1 promoter by recruiting the co-
repressors Ssn6p and Tup1p. The split-ubiquitin system revealed that Mig1p interacts 
with the core histones. The histone mutant proteins H4 Y51A, H4 L90A and H4 K91A, 
which had caused a glucose repression defect when expressed in the place of wild-type 
histone H4, were also defective for the protein-protein interaction with Mig1p, indicating 
a possible mechanism how H4 supports glucose repression of the GAL1 promoter by 
binding to the repressor Mig1p. 
5.2 Results 
5.2.1 Mig1p interacts with core histones 
S. cerevisiae cells expressing Nub together with a fusion of Mig1p to Cub-RUra3p 
grew on plates lacking uracil and failed to grow on plates containing FOA, indicating that 
the Mig1-Cub-RUra3p fusion is enzymatically functional (Figure 5.1, line 1). Co-
expression of Mig1-Cub-RUra3p with Nub fusions to H2A, H2B and H4 allowed the cells 
to grow on FOA plates and prevented growth on plates lacking uracil (Figure 5.1, lines 3, 
4, 6), indicated that Mig1p strongly interacted with those histone proteins. Mig1p also 
interacted with the H2A derivative H2A.Z (Htz1; Figure 5.1, line 2) and with histone H3 
(Figure 5.1, line 5), but to a lesser extent.  
S. cerevisiae cells expressing Nub together with a fusion of Mig2p and Mig3p to Cub-
RUra3p failed to grow on plates lacking uracil, indicating that the Mig2-Cub-RUra3p and 
Mig3-Cub-RUra3p fusions are enzymatically not functional and/or were expressed at 




Figure 5.1 Mig1p interacts with core histone proteins 
S. cerevisiae cells co-expressing the indicated split-ubiquitin fusions were tenfold serially 
diluted, spotted onto the depicted plates and incubated for three days at 28°C. Protein 
interaction is revealed by lack of growth on the plate lacking uracil (UWL) and growth on 
the FOA plate (FWL). 
 
5.2.2 Several histone H4 mutant proteins that are defective for glucose repression are 
also defective for the interaction with Mig1p  
Figure 5.2 shows that cells co-expressing Mig1-Cub-RUra3p together with Nub-H4 
Y51A were able to grow on the plate lacking uracil and failed to grow on the FOA plate 
(line 4), indicating that the H4 Y51 residue is required for the protein interaction with 
Mig1p (compare lines 2 and 4). The protein interaction between Mig1p and histone H4 
was also affected by the H4 L90A and the H4 K91A mutation, but to a lesser extent 
(Figure 5.2, compare lines 2 and 4 with lines 6 and 7), indicating that those two residues 






Figure 5.2  Protein-protein interaction of histone H4 with Mig1p, Mig2p and Mig3p 
S. cerevisiae cells co-expressing the indicated split-ubiquitin fusions were tenfold serially 
diluted, spotted onto the depicted plates and incubated for three days at 28°C. Protein 
interaction is revealed by lack of growth on the plate lacking uracil (UWL) and growth on 
the FOA plate (FWL). 
 
5.3 Discussion 
Mig1p is responsible for repression of many genes that are dispensable to yeast cells 
growing in glucose. The related Mig2p and Mig3p also repress transcription of certain 
genes. Mig1p is a Cys2-His2 zinc-finger containing DNA-binding protein that represses 
transcription by recruiting the general repressors Ssn6p and Tup1p to the promoters of the 
glucose-repressed genes (Treitel and Carlson, 1995). 
In cells grown in the absence of glucose, the SNF1 kinase complex is activated by its 
upstream kinase Sak1, which phosphorylates Snf1 at T210. Activated SNF1, consisting of 
Snf1, Snf4 and Gal83, moves to the nucleus where it phosphorylates Mig1p. 
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Phosphorylated Mig1p is exported into the cytoplasm, thereby preventing it from 
repressing the expression of the glucose-repressed genes in the nucleus. Activated SNF1 
phosphorylates also Mig2p and Mig3p, causing their polyubiquitination and subsequent 
degradation by the 26S proteasome. In yeast cells grown in the presence of glucose, the 
SNF1 kinase complex is inactive and located in the cytoplasm. Mig1p is localized in the 
nucleus, where it binds to promoters of the glucose-repressed genes and represses their 
expression (Hedbacker and Carlson, 2008). 
In order to explore the role of histones in glucose repression, we employed the split-
ubiquitin assay to investigate the interactions of the Mig proteins with histones, as well as 
the interactions of the Mig proteins with those histone H4 mutant proteins that had caused 
defects in glucose repression (Hedbacker and Carlson, 2008). 
H4 Y51A, H4 L90A and H4 K91A had all caused a glucose repression defect of the 
GAL1 promoter when expressed in place of endogenous histone H4, and the same mutant 
proteins were all defective for the protein-protein interaction with Mig1p, which 
establishes glucose repression of the GAL1 promoter by recruiting the co-repressors 
Ssn6p and Tup1p. This indicates that wild-type histone H4 might support glucose 
repression of the GAL1 promoter by binding Mig1p and recruiting it to the GAL1 
promoter. H4 N25A, on the other hand, still interacts with Mig1p even though it also 
causes a glucose repression defect, indicating that histone H4 supports glucose repression 







Chapter 6 Htz1 interconverts chromatin states  
6.1 Abstract 
Upon galactose induction, nucleosomes are evicted from the GAL1 locus in yeast 
cells. Htz1 is required for the eviction of proximal nucleosomes flanking the nucleosome-
free region at the GAL1 promoter and for the transcriptional activation of the GAL1 gene. 
Besides the positive role of Htz1 playing in transcription initiation, we asked if Htz1 also 
plays a role in the glucose repression at the GAL1 promoter. With the help of a fusion of 
the URA3 open reading frame to the GAL1 promoter, we were able to detect two different 
epigenetic transcription states of the GAL1 promoter in glucose-grown cells lacking Htz1: 
a repressed state that is occupied by an H2A-containing nucleosome and a de-repressed 
state that is nucleosome-free. These two chromosomal states are stably inherited through 
many cell divisions. According to the model presented here, the role of Htz1is to facilitate 
the addition and removal of promoter nucleosomes and to prevent the formation of 




6.2.1 Transcriptional activation causes short-term memory 
Defects in the transcriptional activation of the S. cerevisiae GAL1 promoter are 
manifested as growth defects on galactose plates, but defects of its transcriptional 
repression status do not display any growth phenotypes. Previously, a fusion of the GAL1 
promoter to the URA3 ORF was generated in our lab (Lim et al., 2007), which displays 
defects in the glucose repression status of the GAL1 promoter as growth on uracil-
depleted glucose plates and lack of growth on glucose plates containing 5-fluoro orotic 
acid (FOA), as URA3, the gene encoding the enzyme orotidine-5’-phosphate 
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decarboxylase, is required for the biosynthesis of uracil and the conversion of FOA into 
toxic fluoro uracil. The wild-type S. cerevisiae cells transformed with the LYS2-marked 
single-copy vector, Pgal1-Ura317 (that contains a fusion of the GAL1 promoter to the 
URA3 ORF), grew on FOA-containing glucose plates (F) and on uracil-depleted galactose 
plates (G), but not on uracil-depleted glucose plates (U) (Figure 6.1, line 3 and 4), 
reflecting the carbon source regulation of the GAL1 promoter. Due to the glucose 
repression of the GAL1 promoter, URA3 was not expressed in the glucose-grown cells; 
and therefore they grew on the F plate but not on the U plate. For the wild-type cells 
grown on galactose plates, URA3 was expressed as the result of galactose induction of the 
GAL1 promoter. In glucose, Mig1 represses GAL1 expression by recruiting Tup1 to the 
GAL1 promoter. However, in the absence of Tup1, Mig1 facilitates the transcription 
activation of the GAL1 gene (Treitel and Carlson, 1995). TUP1-deleted cells grew on the 
U plate but not on the F plate (Figure 6.1, line 1 and 2), indicating the de-repression of the 
GAL1 promoter in the TUP1 cells and the leaking expression of URA3. 
When the wild-type S. cerevisiae cells were picked from the G plate (Figure 6.1, line 
3) and titrated for a second round onto an F plate, they failed to grow (Figure 6.1, line 9), 
indicating the large amount of Ura3 enzyme still present in the cells even no URA3 
expression going on in these cells during this round of titration. When the cells picked 
from the G plate went through the second round titration on the non-selective uracil-
containing glucose plate (K) (Figure 6.1, line 9), and then titrated for the third round, they 
could grew on the F plate again (Figure 6.1, line 15) as the Ura3 enzyme produced from 
the first round titration had been diluted out during the estimated 25 divisions each cell 
had undergone on the second plate (Meunier and Choder, 1999).  Our observations here 
are reminiscent of the short-term memory of a previous, activated state of transcription 






Figure 6.1 The repression status of the GAL1 promoter in HTZ1 cells is stable 
Cells of the indicated genotype were transformed with the LYS2-marked single-copy 
plasmid, Pgal1-Ura317, expressing URA3 under the control of the GAL1 promoter. Cells 
were tenfold serially diluted and titrated onto lysine-depleted, uracil-containing glucose 
plates (K), lysine-depleted glucose FOA plates (F), uracil-depleted glucose plates (U), and 
uracil-depleted galactose plates (G). Line 1 to line 6 represent the first set of titrations. In 
subsequent titration rounds, cells were taken from the indicated plates of the previous 
rounds, tenfold serially diluted and titrated onto the depicted plates. Line 7 to line 12 
represent the second round of titrations, line 13 to line 18 represent the third round of 
titrations, line 19 to line 23 represent the fourth round of titrations, and line 27 to line 30 










Figure 6.2A Titration scheme: transcriptional activation causes short-term memory 
First round: 10-fold serial dilutions of wild-type BY4742W cells containing the Pgal1-
Ura317 plasmid were titrated on to K, F, U and G plates and incubated for 3 days. The 
cells grew on K, F and G, but not on U plates, reflecting the carbon-source regulation of 
the GAL1 promoter. 
Second round: cells taken from the G plate were 10-fold serially diluted, titrated on to the 
indicated plates and incubated for 3 days. The cells grew well on the K and G plates, 
residually on the U plate and failed to grow on the F plate, indicating that the cells had 
accumulated large amounts of Ura3 enzyme when growing on the G plate. 
Third round: cells which had been grown on the G plate for the first round and on the K 
plate for the second round were 10-fold serially diluted, titrated on to the indicated plates 
and incubated for 3 days. The growth of the cells was the same as that of the first round, 
indicating that no stable chromatin state had been established in the cells during the 
growth on the G plate in the first round titration and that the Ura3 enzyme accumulated in 





















Figure 6.2B Titration scheme: transcriptional repression is stable 
First round: 10-fold serial dilutions of BY4742WHTZ1 cells containing the Pgal1-
Ura317 plasmid were titrated on to the indicated plates and incubated for 3 days. The 
cells grew well on the K, U and G plates, and less well on the F plate, indicating a mixed 
population of cells, a minority of which repressed the GAL1 promoter and a majority of 
which failed to do so. 
Second round: cells taken from the F plate were 10-fold serially diluted, titrated on to the 
indicated plates and incubated for 3 days. The cells grew well on the K, F and G plates, 
whereas they failed to grow on the U plate, indicating that all the cells now repressed the 
GAL1 promoter when grown with glucose. Growth on the G plate indicates that the URA3 
gene had not been damaged by the growth on the F plate and that also the galactose 
induction of the GAL1 promoter was still intact. 
Third round: cells which had been grown on the F plate for the first round and on the K 
plate for the second round were 10-fold serially diluted, titrated on the indicated plates 
and incubated for 3 days. The growth of these cells was exactly the same as that of the 
second round, indicating that the glucose repression status of the GAL1 promoter was 
stable in all the cells. 
Fourth and fifth rounds: cells which had been grown on the F plate for the first round and 
on the K plate for the subsequent rounds were 10-fold serially diluted, titrated on to the 
indicated plates and incubated for 3 days. The cells grew well on the F plate, indicating 
that the glucose repression status of the GAL1 promoter was stable over many generations. 
A few colonies were observed on the U plates indicating that while most cells still stably 
repressed the URA3 gene; a few cells had switched their status and now expressed Ura3p. 
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Figure 6.2C Titration scheme: transcriptional derepression is stable 
First round: 10-fold serial dilutions of BY4742WHTZ1 cells containing the Pgal1-Ura317 
plasmid were titrated on to the indicated plates and incubated for 3 days. The cells grew well on 
the K, U and G plates, and less well on the F plate, indicating a mixed population of cells, a 
minority of which repressed the GAL1 promoter and a majority of which failed to do so. 
Second round: cells taken from the U plate were 10-fold serially diluted, titrated on to the 
indicated plates and incubated for 3 days. Cells grew well on the K, U and G plates, 
whereas they failed to grow on the F plate, indicating that the GAL1 promoter was now 
derepressed in all the cells and that all the cells expressed Ura3p. 
Third round: cells which had been grown on the U plate for the first round and on the K 
plate for the second round were 10-fold serially diluted, titrated on to the indicated plates 
and incubated for 3 days. The growth of these cells was exactly the same as that of the 
second round, indicating that the derepression status of the GAL1 promoter was stable and 
that all the cells expressed Ura3p. 
Fourth and fifth round: cells which had been grown for the first round on the U plate and 
for the subsequent rounds on the K plates were 10-fold serially diluted, titrated on to the 
indicated plates and incubated for 3 days. A few colonies were observed on the F plates, 
indicating that while the GAL1 promoter was still derepressed in most cells as they 
expressed Ura3p, a few cells had switched the expression status of the GAL1 promoter 






6.2.2 A mixed population of repression-deficient and repression-competent HTZ1 
cells 
S. cerevisiae cells lacking Htz1 are known to be defective for the transcriptional 
activation of the GAL genes, but since histones are also known to play a role in 
transcriptional repression of several genes, we asked if HTZ1 cells are defective for the 
transcriptional repression of GAL genes as well. HTZ1 cells containing Pgal1-Ura317 
grew on both F plates and U plates (Figure 6.1, line 5 and line 6), indicating a mixed 
population of cells, with either the repressed GAL1 promoter or the de-repressed GAL1 
promoter.  When these HTZ1 cells were transformed additionally with a single-copy 
vector carrying the HTZ1 gene, they grew like wild-type cells, indicating that the absence 
of Htz1 had caused the difference in growth. When Htz1-lacking cells were picked from 
the F plate (Figure 6.1, line 5) and titrated for a second round, they grew on the F plate, 
but not on the U plate (Figure 6.1, line 12). In contrast, the cells taken from the U plate 
(Figure 6.1, line 5) were found to grow on the U plate, but not on the F plate (Figure 6.1, 
line 11), indicating that the mixed population of cells observed during the first round had 
been sorted out in the second round. 
One of the causes of the growth differences could be that the HTZ1 cells had 
acquired chromosomal mutations during the growth under selective conditions. The first 
three rounds of titrations were repeated with diploid BY4743WHTZ1 cells and the 
result was the same as for the haploid cells, indicating the chances that the differences in 
growth had been caused by host mutations would be very slim (Zhao et al., 2011). In 
order to further confirm this, the HTZ1 cells from U plates and F plates (Figure 6.1, line 
5) were cured of the plasmid and retransformed with the original Pgal1-Ura317 plasmid. 
The cured cells behaved the same as those in the first round of titrations, therefore, 
excluding the possibility that any chromosomal host mutation that could have occurred 
during the growth under selective conditions, had caused those differences. 
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Another possible explanation for the growth differences is that the mutations induced 
by the lack of Htz1 (which might affect the fidelity of DNA replication, increasing the 
mutation rate) might have occurred in the Pgal1-Ura317 plasmid during the growth under 
selective conditions. The Pgal1-Ura317 plasmids from HTZ1 cells grown under 
selective conditions on U and F plates were isolated and the Pgal1-URA3 segment was 
sequenced. The sequencing results showed that there was no sequence difference between 
the plasmid isolated from cells grown on the U plate and those on the F plate, indicating 
that the difference in growth on the U and F plate had not been caused by mutations in the 
GAL1 promoter nor in the URA3 gene. However, it was found that there were eight point-
variations in the DNA sequence of the vector GAL1 promoter as compared to the 
sequence published in the Saccharomyces genome database (SGD). It turned out that the 
variations on the plasmid were originated from the S288C strain (GenBank accession 
number: NC_001134.7) and the ATCC genomic library #77162, which had been used to 
clone the GAL1 promoter. When the experiment was repeated with a plasmid containing 
the identical GAL1 promoter sequence published in SGD, which is present in the 
BY4742W strain, the results were comparable to those from the earlier experiments 
carried out using the S288C originated plasmid, indicating that the eight point-variations 
in the DNA sequence of the vector GAL1 promoter did not significantly affect glucose 
repression. 
After excluding the above possible causes, there is still another possible explanation 
for the growth differences, i.e., the copy-number of the plasmid was higher in the cells 
picked from the U plate than those from the F plate. However, quantitative real-time PCR 
indicated that the ratio of the episomal S288C GAL1 promoter to the chromosomal 
BY4742W GAL1 promoter was the same in the cells picked from the U and F plates, 




6.2.3 The transcription status of the episomal GAL1 promoter in HTZ1 cells is 
stable  
The memory of the activated transcription status of the GAL1 promoter was lost after 
the cells went through one round of growth on the glucose plate (i.e., under repressing 
conditions) (Figure 6.1, line 24 to line 26), and we asked if the two different transcription 
states that has been observed for the GAL1 promoter in glucose-grown HTZ1 cells, 
would persist through several rounds of growth under non-selective conditions. Glucose 
repression-competent HTZ1 cells, which had been selected for by growth on the F plate 
(Figure 6.1, line 5), were titrated on a K plate for a second round of non-selective growth 
(Figure 6.1, line 18). The third-round titration of these cells showed that they could grow 
on the F plate, but not the U plate. In contrast, glucose repression-deficient HTZ1 cells, 
which had been selected for by growth on the U plate (Figure 6.1, line 5), grew on the U 
plate, but not the F plate in the third-round titration (Figure 6.1, line 17) after undergoing 
the second round growth on non-selective plate (Figure 6.1, line 11). These observations 
indicated that both transcription states of the GAL1 promoter in HTZ1 cells were stable. 
In the fourth round of titrations, the transcription status of the GAL1-URA3 fusion in 
remained stable under non-selective conditions for the vast majority of cells, with less 
than 1% of the first-round cells grown on the F plate losing glucose repression and 
forming colonies on the U plate (Figure 6.1, line 22), and less than 1% of the first-round 
cells grown on the U plate regaining glucose repression and forming colonies on the F 
plate (Figure 6.1, line 23). The few cells that had switched their transcription status were 
included in subsequent titration rounds, and the switched transcription status was found to 
be stable, too (Figure 6.1, line 29 and line 30). During the eight rounds of growth under 
non-selective conditions, corresponding to an estimated 200 cell divisions (Meunier and 
Choder, 1999), the transcription status of the Pgal1-URA3 fusion remained stable for the 
vast majority of cells (Figure 6.1, line 28), and the experiment was terminated. The long-
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term persistence of the transcription status observed in the absence of Htz1 suggests that 
the function of Htz1 is to allow for the conversion between two stable epigenetic 




6.6.4 The transcription status of the chromosomal GAL1 promoter in HTZ1 cells is 
also stable 
 The titration results presented in Figure 6.1 employed an episomal GAL1 promoter, 
which might have a different chromatin structure from the GAL1 promoter that is present 
on the chromosome. Therefore, the URA3 ORF was integrated into the chromosomal 
GAL1 locus of wild-type, TUP1-deleted and HTZ1-deleted BY4742W cells. All 
integration events were confirmed by DNA sequencing. All colonies picked for the wild-
type cells grew on F plates but not on U plates (Figure 6.3, line 3 and line 4), whereas all 
colonies picked for the TUP1-deleted cells grew on U plates but not on F plates (Figure 
6.3, line 1 and line 2). For the HTZ1-deleted cells, two out of eight colonies picked grew 
predominantly on the U plate (Figure 6.3, line 5 and line 6), while the rest six colonies 
grew predominantly on the F plate (two out of these six colonies picked are shown in 
Figure 6.3, line 7 and line 8). Wild-type cells displayed the same short-term memory of 
transcriptional activation that had been observed for observed for the episomal GAL1 
promoter (Figure 6.3, line 27 to line 29), whereas the HTZ1 cells displayed the same 
long-term persistence of the transcription status that had been observed for the single-
copy vector (Figure 6.3). 
In this experimental set-up, the first possible cause for the growth differences to be 
excluded is the mutations that could have occurred in the Pgal1-URA3 locus during the 
growth under selective conditions. The genomic DNA of HTZ1 cells grown on U plates 
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and F plates was isolated and the Pgal1-URA3 fusion was amplified by PCR and then 
sequenced. No mutation in DNA sequence was found for cells of the same strain form U 
plates and F plates, indicating that the difference in growth on the U plate and the F plate 
had not been caused by mutations in the GAL1 promoter and the URA3 gene.  The above 
experiments had been performed with the GAL1 promoter sequence of S288C. When the 
experiments were repeated with an integrative vector containing the GAL1 promoter 
sequence from BY4742, the results were comparable to the previous results, indicating 
that the changes in the DNA sequence of the GAL1 promoter did not significantly affect 
glucose repression and the epigenetic inheritance of the transcription status. During 9 
rounds of growth under non-selective conditions, corresponding to an estimated 225 cell 
divisions (Meunier and Choder, 1999), the transcription status of the Pgal1-URA3 fusion 
remained stable for the vast majority of cells (Figure 6.3, line 31), and the experiment was 
terminated. Since the cells in Figure 6.3, line 21 and line 24, had not been exposed to U 
plates or F plates prior to the titration, the different URA3 expression status of them was 
not ectopically induced by the growth under selective conditions, and therefore indicated 
the transcription status of the GAL1 promoter at the time of the integration of URA3 ORF 








Figure 6.3 The repression status of the chromosomal GAL1 promoter in HTZ1 cells 
is stable 
The URA3 gene was integrated into the GAL1 chromosomal locus of BY4742W cells of 
the indicated genotype with the help of the TRP1-marked integration plasmid. Cells were 
tenfold serially diluted and titrated onto tryptophan-depleted, uracil-containing glucose 
plates (W), tryptophan-depleted glucose FOA plates (F), uracil-depleted glucose plates 
(U), and uracil-depleted galactose plates (G). Line 1 to line 8 represent the first set of 
titrations. In subsequent titration rounds, cells taken from the indicated plates of the 
previous rounds, were tenfold serially diluted and titrated onto the depicted plates. Line 9 
to 17 represent the second round of titrations, line 18 to line 26 represent the third round 
of titrations, and line 31 and line 32 represent the eleventh round of titrations. W and G 
plates were incubated for three days at 28C, while U and F plates were incubated for six 




6.6.5 The growth on U plates and F plates reflects the GAL1 transcription status 
Growth on reporter plates indicates a certain transcription status, however, this has to 
be confirmed by the respective mRNA levels. Reverse transcription-coupled with real-
time PCR was used to determine the level of GAL1 mRNA relative to ACT1 mRNA in 
glucose-grown and galactose-induced wild-type and HTZ1 cells. Figure 6.4A shows that 
an 8-hour galactose induction caused a 2,800-fold increase of GAL1 mRNA level in wild-
type cells, but only a 500-fold increase in HTZ1 cells, consistent with the previously 
reported galactose activation defect of the cells lacking Htz1. However, only a 1.8-fold 
increase of GAL1 mRNA level was measured in HTZ1 cells grown in glucose liquid 
medium as compared with glucose-grown wild-type cells. Obviously, this mild increase 
was not enough to confirm the significant glucose repression defect demonstrated by the 
HTZ1 cells grown on the U plates. The most likely explanation for this is that GAL1 
mRNA, like the mRNAs of other glucose-repressed genes, is stable when the cells are 
grown in galactose liquid medium, but rapidly degraded when the cells are switched to 
glucose liquid medium (Cereghino and Scheffler, 1996). In order to confirm this was 
indeed the case, we induced BY4742W cells in galactose liquid media for 24 hours with 
or without the presence of the transcription inhibitor, thiolutin (Coller, 2008). In the 
presence of thiolutin, the GAL1 mRNA level in the galactose-induced cells was the same 
as that in the glucose-grown cells (Figure 6.4B, blocked), whereas in the absence of 
thiolutin, the GAL1 mRNA level in the galactose-induced cells was more than 1,000-fold 
higher than that in glucose-grown cells (Figure 6.4B, 0 min). When the cells induced with 
galactose for 24 hours in the absence of thiolutin were switched to fresh galactose liquid 
media containing thiolutin, the GAL1 mRNA level remained unchanged, suggesting that 
GAL1 mRNA is stable in the galactose-grown cells. In contrast, when the cells were 
shifted to glucose liquid medium containing thiolutin instead, the GAL1 mRNA was 
degraded rapidly, explaining why the glucose repression defect of the GAL1 gene in 
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HTZ1 cells had not been detected previously (DeRisi et al., 1997; Gligoris et al., 2007; 
Meneghini et al., 2003; Zhang et al., 2005). 
Reverse transcription-coupled with real-time PCR was used to determine the 
expression level of URA3 mRNA relative to ACT1 mRNA in strains expressing URA3 
from the GAL1 chromosomal locus that had been picked from the different plates in 
Figure 6.3. The deletion of TUP1 caused a 160-fold increase in URA3 mRNA level 
(Figure 6.4C), reflecting the growth of TUP1 cells on U plates. In the HTZ1 #1 strain, 
no increased URA3 mRNA level was observed for the cells from the W plate or the F 
plate, while a 65-fold increase was observed for those from the U plate. For HTZ1 #3 
strain, a 50-fold and 60-fold increase of URA3 mRNA was observed, when the cells had 
been picked from the W plate or the U plate, respectively, while no increase was observed 
when the cells from the F plate, indicating that the growth on U plates and F plates 
reflected the transcription status of the integrated Pgal1-URA3 fusion on chromosomes. 
Note that the cells labeled W in Figure 3C had not been exposed to U plates or F plates 
prior to the isolation of RNA, demonstrating that the difference in the transcription status 
of the GAL1 promoter could not have been ectopically induced by growth under selective 

























Figure 6.4A The indicated strains were grown in glucose liquid media to OD600nm = 1 and 
induced in galactose liquid media for the indicated number of hours. Total RNA was 
isolated and the amount of GAL1 mRNA relative to ACT1 mRNA was determined by 
quantitative real-time PCR. The relative value of wild-type BY4742W cells grown with 





Figure 6.4B Wild-type BY4742W cells were grown in glucose liquid media to OD600nm 
= 1 and induced with galactose liquid media for 24 hours in the presence of thiolutin 
(blocked) or in the absence of thiolutin. The cells that had been induced in the absence of 
thiolutin were switched to fresh thiolutin–containing glucose (Glu) and galactose (Gal) 
media. Cells were harvested at the indicated number of minutes after they had been 
switched to fresh media and the total RNA was isolated. The amount of GAL1 mRNA 
relative to ACT1 mRNA was determined by quantitative real-time PCR. The value 
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determined for cells grown in glucose was set as 1 and the error bars indicate the standard 





Figure 6.4C The depicted strains were picked from the indicated plates and grown in 
glucose to OD600nm = 1. The total RNA was isolated and the amount of URA3 mRNA 
relative to ACT1 mRNA was determined by quantitative real-time PCR. The relative 
amount of URA3 mRNA in wild-type BY4742W cells was set as 1 and the error bars 
indicate the standard deviation of three replicates.  
 
6.6.6 Galactose induction evicts nucleosomes from the GAL1 locus 
Chromatin immunoprecipitation (ChIP) can be used to determine nucleosome 
occupancy of chromosomal DNA in vivo. An Htz1-containing nucleosome occupies the 
+1 position at the GAL1 promoter (Albert et al., 2007; Bryant et al., 2008). Histone H2B 
was chromosomally tagged with three HA epitopes and 10 histidines and used for ChIP-
coupled with real-time PCR in order to determine the chromatin status of the GAL1 locus. 
Consistent with previous report (Albert et al., 2007; Bryant et al., 2008), a nucleosome 
was detected at the GAL1 promoter, which was evicted when cells were induced for 4 
hours with galactose (Figure 6.5A). Similar results were observed for the GAL1 ORF 
(Figure 6.5B), indicating that the entire GAL1 locus becomes nucleosome free upon 
galactose induction. In HTZ1 cells grown with glucose, H2B was still detected at the 
GAL1 promoter, indicating the occupancy of H2A-containing nucleosomes at the GAL1 
95 
 
promoter in the majority ofHTZ1 cells (Figure 6.5A). The GAL1 promoter nucleosomes 
remained intact in most HTZ1 cells when they were induced with galactose for four 
hours (Figure 6.5A), consistent with previous findings that the GAL1 activation defect in 
the cells lacking Htz1.  
 
 
Figure 6.5 Galactose induction evicts nucleosomes from the GAL1 locus  
Endogenous H2B of indicated strains was C-terminally tagged with three HA epitopes 
and ten histidines. Cells were grown in glucose liquid media to OD600nm = 1 and induced 
in galactose liquid media for four hours. Crosslinked proteins were precipitated with anti-
HA beads. Quantitative real-time PCR was used to determine the percent 
immunoprecipitation for the GAL1 promoter (A) and the GAL1 ORF (B) relative to the 
percent immunoprecipitation obtained for the unrelated ZDS1 promoter. The error bars 
indicate the standard deviation of three replicates. 
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6.6.7 Nucleosome occupancy reflects the transcription status of the GAL1 locus 
The titration results presented in Figure 6.1 and Figure 6.3 indicate that there is a 
mixture of glucose repression-competent and glucose repression-deficient HTZ1 cells. 
The nucleosome ChIP signal obtained for the GAL1 promoter in the glucose-grown 
HTZ1 cells in Figure 6.5A might have been solely due to the glucose repression-
competent cells in the mixture, while the GAL1 promoter in the glucose repression-
deficient cells could have been nucleosome free. The integration of the URA3 ORF into 
the GAL1 locus allows for the separation of the mixture into glucose repression-
competent and glucose repression-deficient cells. We repeated the ChIP experiments with 
the glucose-grown cells that had been picked from F plates and U plates. Figure 6.6A 
shows that the GAL1 promoter of repression-competent HTZ1 cells (that had been 
picked from the F plate of Figure 6.3, line 6 and line 8) was nucleosome occupied, while 
the GAL1 promoter of glucose repression-deficient HTZ1 cells (that had been picked 
from the U plate of Figure 6.3, line 6 and line 8) was nucleosome free. Similar results 
were obtained for the URA3 ORF (Figure 6.6B), suggesting that the stable URA3 
transcription status of the cells picked from the F plates and the U plates was reflecting 
the two different stably inherited chromatin structures at the Pgal1-URA3 locus, an active 















Figure 6.6 Nucleosome occupancy reflects the repression status of GAL1 
Endogenous H2B of the indicated strains that had been picked from the depicted plates 
was C-terminally tagged with three HA epitopes and ten histidines. Proteins of glucose-
grown cells were crosslinked and precipitated with anti-HA beads. Quantitative real-time 
PCR was used to determine the percent immunoprecipitation for the URA3-linked GAL1 
(S288C) promoter (A) and the URA3 ORF (B) relative to the percent 
immunoprecipitation obtained for the unrelated ZDS1 promoter. The error bars indicate 





The term “epigenetic memory of transcription” has been used to describe the 
increased speed of galactose induction of the GAL1 transcription in the cells with 
previous exposure to galactose (Kundu et al., 2007). The titration presented in Figure 6.1, 
line 24 to line 26, and Figure 6.3, line 27 to line 29, showed the slightly elevated URA3 
expression level in the glucose-grown cells which had been grown on galactose plates in 
the previous titration round, which is reminiscent of this phenomena. Subsequently, 
however, it has been reported that the epigenetic memory had been due to the Gal1 
enzymes present in the cells with the previous exposure to galactose, rather than the 
memory of the activated GAL1 transcription state (Zacharioudakis et al., 2007). This is 
fully consistent with the results presented here, as the increased growth on the uracil-
depleted glucose plates and the reduced growth on the FOA-containing glucose plates of 
cells that had been grown on the uracil-depleted galactose plates can be explained by the 
temporary persistence of Ura3 proteins in the cells following their switch to glucose 
plates. In contrast, the stable transcription states of HTZ1 cells presented in the titration 
results here are totally different case, as they are describing the persistence of a particular, 
stable transcription state rather than the temporary memory of a previous transcription 
state. 
Previous work had identified the histone variant H2A.Z, which is present in the +1 
nucleosome at the GAL1 promoter, as a positive factor for GAL1 transcription upon 
galactose induction, due to the reduced transcriptional activation of GAL1 gene in HTZ1 
cells (Gligoris et al., 2007). Here we have shown that Htz1 is also required for the 
establishment of transcriptional repression at the GAL1 promoter. This function of Htz1 
has been overlooked by previous studies, as transcription activity is conventionally 
measured by the steady state levels of mRNAs, while the GAL1 mRNA transcribed in 
glucose is degraded so rapidly that any difference of it levels is barely detectable. Our 
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results regarding the instability of the GAL1 mRNA of cells grown in glucose media are 
fully consistent with the reported kinetics of GAL1 mRNA in glucose shut-down 
experiments with cells pre-grown in galactose media (inducing conditions) (Gromoller 
and Lehming, 2000). The GAL1 mRNA disappears within minutes upon the exposure of 
galactose-grown cells to glucose, which can only be explained by mRNA degradation. 
We failed to detect any significant level of GAL1 mRNA in glucose-grown HTZ1 
cells (Figure 6.4A), and we believe that this was due to the rapid degradation of GAL1 
mRNA in glucose-grown cells. Moderately elevated level (66-fold) of URA3 mRNA 
transcribed from the URA3 ORF which had been inserted into the GAL1 locus was 
detected in the glucose-grown repression-deficient HTZ1 cells.  
The role of Tup1 protein in glucose repression of the GAL1 promoter had been 
established with the help of GAL1-lacZ reporter fusion (Gligoris et al., 2007; Gromoller 
and Lehming, 2000). However, neither our study nor others’ have detected significant 
levels of the GAL1 mRNA in glucose-grown TUP1 cells. The discrepancy between the 
published GAL1 mRNA and GAL1-lacZ results for TUP1 cells, as well as the quick 
disappearance of the GAL1 mRNA in galactose-grown cells following their switch to 
glucose media (Bryant et al., 2008) strongly suggested that the GAL1 mRNA is highly 
unstable in glucose-grown cells. Therefore, we tested the stability of the GAL1 mRNA in 
glucose-grown cells, and confirmed that GAL1 mRNA was indeed rapidly degraded upon 
the switch of galactose-grown cells to glucose media (Figure 6.4B).  
In glucose-grown wild type cells, an Htz1-containing nucleosome occupies the +1 
position at the GAL1 promoter (Figure 6.7A). In the absence of Htz1, there is a mixed 
population of cells (Figure 6.7B). In the majority of glucose-grown HTZ1 cells, the 
GAL1 promoter is occupied with an H2A-containing nucleosome. Transcriptional 
repression is intact in these cells, and with the fusion of URA3 ORF to the GAL1 promoter, 
they can grow on glucose plates containing FOA, but fail to grow on glucose plates 
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lacking uracil. However, in a small population of the glucose-grown HTZ1 cells, their 
GAL1 promoters were nucleosome-free. Transcriptional repression at the GAL1 locus 
cannot be established in those cells and they are viable on glucose plates lacking uracil, 
but dead on glucose plates containing FOA. It is important to note that transcriptional de-
repression produces much less mRNA than transcriptional activation. While 
transcriptional activation by Gal4 protein increases the level of GAL1 mRNA by 2,800 
folds, the augment of URA3 mRNA transcribed under the control of the GAL1 promoter 
observed for the repression-deficient HTZ1 cells, was only some 50 to 65 folds.  
We do not believe that the cell growth on uracil-depleted glucose plates is due to the 
induction of the GAL1 promoter and the growth on FOA-containing plates is due to the 
repression of it, as Ppr1 protein, the activator of the URA3 gene, has no effect on the 
GAL1 promoter. Rather, we believe that there is a mixture of repression-deficient and 
repression-competent Htz1-lacking cells that can be separated on uracil-depleted plates 
and on FOA-containing plates once the URA3 ORF has been placed under the control of 
the GAL1 promoter. We would like to point out that the respective selection into glucose 
repression-deficient HTZ1 cells on uracil-depleted plates and into glucose repression-
competent HTZ1 cells on FOA-containing plates was carried out only for the 
experiments featuring the episomal GAL1 promoter presented in Figure 6.1, where scoops 
of approximately ten transformants had been subjected to 10-fold serial dilutions prior to 
the titrations. For the experiments with the chromosomal GAL1 promoter presented in 
Figure 6.3, individual colonies had been picked from uracil-containing plates, which did 
not select for or against the expression of the Pgal1-URA3 reporter (the plates was only 
lacking tryptophan to select for the integration of the URA3 ORF into the GAL1 locus). 
The colonies had been amplified on tryptophan-lacking plates and the titrations on uracil-
depleted plates and FOA-containing plates served only to determine which colonies 
consisted of glucose-deficient HTZ1 cells (colony #3 and colony #4; line 5 and line 6 
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respectively) and which colonies consisted of glucose repression-competent HTZ1 cells 
(colony #1 and colony #2; line 7 and line 8 respectively), but the respective 
transcriptional states could not have been caused by selective conditions, as the cell had 
not been exposed to these conditions previously (Figure 6.3, compare line 21 and line 24; 
WW means that the cells had never been exposed to uracil-depleted media or FOA-
containing media). 
The percentage of Htz1-lacking cells whose GAL1 promoter is nucleosome free can 
be estimated from the 10-fold serial dilutions of cells presented in Figure 6.1 and Figure 
6.3.The results presented in Figure 6.1 suggest that an H2A-containing nucleosome 
occupies the episomal GAL1 promoter in about 1% of HTZ1 cells, while 99% of the 
episomal GAL1 promoter remains nucleosome free. The results presented in Figure 6.3 
indicate that an H2A-containing nucleosome occupies the chromosomal GAL1 promoter 
in about 75% of HTZ1 cells, while 25% remained nucleosome free. The inheritance of 
these two chromatin states of the GAL1 promoter on both the episome and the 
chromosome is completely stable. Only very few cells are able to switch to the other state 
and once switched, they remain in the new state. The chromatin state is not restricted to 
the GAL1 promoter nucleosome but extends also to the URA3 ORF, which also exists in 
two states, i.e., an active, nucleosome-free state and an inactive, nucleosome-occupied 
state. Since Htz1 is also required for the removal of the GAL1 promoter nucleosome upon 
galactose induction, we conclude that Htz1 is required both for the fast removal of the 
nucleosome at the GAL1 promoter upon galactose induction and the addition of it in 
glucose. According to the model presented here, the role of Htz1 is to facilitate the 
addition and removal of promoter nucleosomes and to prevent the formation of 
unfavorable stable epigenetic chromatin structures, which are not in accordance with the 
environmental conditions.  
H2A.Z activates transcription in conjunction with remodelers and is required for the 
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repression of ~100 euchromatic genes. The data obtained in recent years through the use 
of genome-wide location analysis showed that H2A.Z is associated with thousands of 
genomic loci scattered throughout all yeast chromosomes. A striking feature of the 
distribution pattern of H2A.Z is the significant enrichment in promoter regions. There is a 
H2A.Z locus upstream of every ORF. About 75% of all H2A.Z loci are within promoter 
regions of annotated genes, but not all promoters are decorated with H2A.Z (around 37% 







Figure 6.7 Htz1 is required to establish glucose repression in all cells 
(A) Schematic drawing depicting the chromatin status of the GAL1 promoter in wild-
type cells grown in glucose and in galactose. In all wild-type cells grown in glucose, the 
GAL1 promoter is repressed and occupied by an Htz1-containing nucleosome, whereas in 
all wild-type cells grown in galactose, the GAL1 promoter is activated and nucleosome-
free.  
(B) Schematic drawing depicting the chromatin status of the GAL1 promoter in 
glucose-grown cells lacking Htz1. In majority of glucose-grown HTZ1 cells, the GAL1 
promoter is repressed and occupied by an H2A-containing nucleosome, whereas in a 
minority of glucose-grown HTZ1 cells, the GAL1 promoter is depressed and 
nucleosome-free. In the absence of Htz1, both transcription states and chromatin states 






Chapter 7 Conclusion 
Gene deletion is the best way to determine the function of a protein in the cell. This 
method is not applicable to the most important genes like the histones, as they are 
essential for cell viability and cannot be deleted. However, the sophisticated genetic tools 
that are available for the model eukaryote Saccharomyces cerevisiae enable us to study 
even the functions of essential genes. Alanine-scanning mutagenesis coupled with 
plasmid shuffling was used to exchange wild-type histones H2A and H4 with alanine 
point mutant proteins. This revealed those histone residues that were essential for cell 
viability. The remaining viable histone mutant strains were tested for growth defects 
under conditions that require the function of the transcriptional activators and repressors 
Gal4, Gcn4p, Ppr1p and Mig1p. Cells expressing the histone H2A mutant protein H2A 
E57A in place of wild-type H2A were unable to grow on galactose plates in the presence 
of the respiration inhibitor antimycin A just like cells missing Gal4p. Wild-type H2A 
protein interacted with Gal4p in the split-ubiquitin assay and the H2A E57A mutant 
protein failed to do, indicating that Gal4p might have to interact with H2A when it binds 
to its sites in the promoters of the GAL genes. The failure to do so would result in the 
failure of Gal4p to bind to its sites and the failure to recruit those transcription factors to 
the GAL genes that are required to activate transcription. Chromatin immunoprecipitation 
(ChIP) with an anti-Gal4p antibody will have to be performed in order to confirm this 
hypothesis. If the results show that Gal4p is still bound to its sites in the H2A E57A 
mutant strain, ChIP could be performed with antibodies against the other transcription 
factors that are recruited to the promoters of the GAL genes in the course of galactose 
induction like the TATA-binding protein TBP, General Transcription Factors (GTFs), 
chromatin remodeling and chromatin modifying complexes, and RNA Polymerase II. 
Factors that are not recruited to the GAL gene promoters in the H2A E57A mutant strain 
could be tested for protein interaction with H2A and with the H2A E57A mutant protein 
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in the Split-Ubiquitin assay in order to determine the cause for gal phenotype of the H2A 
E57A mutant strain. 
Mig1p represses the promoters of the GAL genes when S. cerevisiae cells are growing 
in glucose media, and thus wild-type cells expressing the URA3 gene under the control of 
the GAL1 promoter are able to grow on glucose FOA plates. Cells expressing the H4 
Y51A mutant protein in place of wild-type H4 were unable to grow on glucose FOA 
plates, indicating that histone H4 and nucleosomes play an important role in the glucose 
repression of the GAL genes. Mig1p interacts with wild-type H4 and fails to interact with 
the H4 Y51A mutant protein in the split-ubiquitin assay, indicating that Mig1p might have 
to interact with H4 in order to bind to its sites in the promoters of the GAL genes. The 
failure to do so would result in the failure of Mig1p to bind to its sites and the failure to 
recruit those transcription factors to the GAL genes that are required to repress 
transcription. Chromatin immunoprecipitation (ChIP) with an anti-Mig1p antibody will 
have to be performed in order to confirm this hypothesis. If the results show that Mig1p is 
still bound to its sites in the H4 Y51A mutant strain, ChIP could be performed with 
antibodies against the other transcription factors that are recruited to the promoters of the 
GAL genes in the course of glucose repression like Ssn6p, Tup1p, and chromatin 
modifying complexes. Factors that are not recruited to the GAL gene promoters in the H4 
Y51A mutant strain could be tested for protein interaction with H4 and with the H4 Y51A 
mutant protein in the Split-Ubiquitin assay in order to identify the cause for the glucose 
repression defect of the H4 Y51A mutant strain. 
H4 K91A, which also caused a glucose repression defect when expressed in the place 
of wild-type histone H4, was defective for the protein-protein interactions with the other 
core histones in the split-ubiquitin assay. This indicates that stable nucleosomes are 
required for glucose repression of the GAL genes. ChIP with anti-histone antibodies could 
be used to confirm that there are fewer nucleosomes occupying the GAL genes in the 
106 
 
glucose-grown H4 K91A mutant strain than in the glucose-grown wild-type strain. 
The H2A variant H2A.Z was found to be required for both galactose induction and 
glucose repression of the GAL1 gene. However, not all cells lacking H2A.Z were 
defective for glucose repression of the GAL1 promoter, as it was de-repressed in a subset 
of H2A.Z-lacking cells only. The repression status of the GAL1 promoter in H2A.Z, 
lacking cells was found to be stably inherited through many generations, indicating that 
the role of H2A.Z in glucose repression is to help establish the repressed chromatin state 
at the GAL1 gene. H2A.Z-lacking cells are also defective for galactose induction of the 
GAL1 gene, indicating that H2A.Z is required to switch the GAL1 gene between the 
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